ParkinsonCanadaV1, Pmc, Corpus, bibRecord, 000920

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

Identifieur interne : 000920 ( Pmc/Corpus ); précédent : 000919; suivant : 000921

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

Auteurs : Ruth-Mary Desouza ; Elena Moro ; Anthony E. Lang ; Anthony H V. Schapira

Source :

Annals of Neurology [ 0364-5134 ] ; 2013.

RBID : PMC:4065356

Abstract

We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy.

Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD.

Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS.

If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility. Ann Neurol 2013;73:565–575

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065356

DOI: 10.1002/ana.23890
PubMed: 23483564
PubMed Central: 4065356

Links to Exploration step

PMC:4065356

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?</title>
<author><name sortKey="Desouza, Ruth Mary" sort="Desouza, Ruth Mary" uniqKey="Desouza R" first="Ruth-Mary" last="Desouza">Ruth-Mary Desouza</name>
<affiliation><nlm:aff id="au1"><institution>Department of Clinical Neurosciences, Institute of Neurology, University College London</institution>
<addr-line>London, United Kingdom</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
<affiliation><nlm:aff id="au2"><institution>Movement Disorders Center, Department of Psychiatry and Neurology, University Hospital Center of Grenoble</institution>
<addr-line>Grenoble, France</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<affiliation><nlm:aff id="au3"><institution>Toronto Western Hospital</institution>
<addr-line>Toronto, Ontario, Canada</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation><nlm:aff id="au1"><institution>Department of Clinical Neurosciences, Institute of Neurology, University College London</institution>
<addr-line>London, United Kingdom</addr-line>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23483564</idno>
<idno type="pmc">4065356</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065356</idno>
<idno type="RBID">PMC:4065356</idno>
<idno type="doi">10.1002/ana.23890</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000920</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000920</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?</title>
<author><name sortKey="Desouza, Ruth Mary" sort="Desouza, Ruth Mary" uniqKey="Desouza R" first="Ruth-Mary" last="Desouza">Ruth-Mary Desouza</name>
<affiliation><nlm:aff id="au1"><institution>Department of Clinical Neurosciences, Institute of Neurology, University College London</institution>
<addr-line>London, United Kingdom</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Moro, Elena" sort="Moro, Elena" uniqKey="Moro E" first="Elena" last="Moro">Elena Moro</name>
<affiliation><nlm:aff id="au2"><institution>Movement Disorders Center, Department of Psychiatry and Neurology, University Hospital Center of Grenoble</institution>
<addr-line>Grenoble, France</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<affiliation><nlm:aff id="au3"><institution>Toronto Western Hospital</institution>
<addr-line>Toronto, Ontario, Canada</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Schapira, Anthony H V" sort="Schapira, Anthony H V" uniqKey="Schapira A" first="Anthony H V" last="Schapira">Anthony H V. Schapira</name>
<affiliation><nlm:aff id="au1"><institution>Department of Clinical Neurosciences, Institute of Neurology, University College London</institution>
<addr-line>London, United Kingdom</addr-line>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of Neurology</title>
<idno type="ISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy.</p>
<p>Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD.</p>
<p>Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS.</p>
<p>If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility. Ann Neurol 2013;73:565–575</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Twelves, D" uniqKey="Twelves D">D Twelves</name>
</author>
<author><name sortKey="Perkins, Ks" uniqKey="Perkins K">KS Perkins</name>
</author>
<author><name sortKey="Counsell, C" uniqKey="Counsell C">C Counsell</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wickremaratchi, Mm" uniqKey="Wickremaratchi M">MM Wickremaratchi</name>
</author>
<author><name sortKey="Ben Shlomo, Y" uniqKey="Ben Shlomo Y">Y Ben-Shlomo</name>
</author>
<author><name sortKey="Morris, Hr" uniqKey="Morris H">HR Morris</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dorsey, Er" uniqKey="Dorsey E">ER Dorsey</name>
</author>
<author><name sortKey="Constantinescu, R" uniqKey="Constantinescu R">R Constantinescu</name>
</author>
<author><name sortKey="Thompson, Jp" uniqKey="Thompson J">JP Thompson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Findley, Lj" uniqKey="Findley L">LJ Findley</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Vossius, C" uniqKey="Vossius C">C Vossius</name>
</author>
<author><name sortKey="Nilsen, Ob" uniqKey="Nilsen O">OB Nilsen</name>
</author>
<author><name sortKey="Larsen, Jp" uniqKey="Larsen J">JP Larsen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Winter, Y" uniqKey="Winter Y">Y Winter</name>
</author>
<author><name sortKey="Balzer Geldsetzer, M" uniqKey="Balzer Geldsetzer M">M Balzer-Geldsetzer</name>
</author>
<author><name sortKey="Spottke, A" uniqKey="Spottke A">A Spottke</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Weintraub, D" uniqKey="Weintraub D">D Weintraub</name>
</author>
<author><name sortKey="Comella, Cl" uniqKey="Comella C">CL Comella</name>
</author>
<author><name sortKey="Horn, S" uniqKey="Horn S">S Horn</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chen, Jj" uniqKey="Chen J">JJ Chen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chaudhuri, Kr" uniqKey="Chaudhuri K">KR Chaudhuri</name>
</author>
<author><name sortKey="Healy, Dg" uniqKey="Healy D">DG Healy</name>
</author>
<author><name sortKey="Schapira, Ah" uniqKey="Schapira A">AH Schapira</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Deuschl, G" uniqKey="Deuschl G">G Deuschl</name>
</author>
<author><name sortKey="Schade Brittinger, C" uniqKey="Schade Brittinger C">C Schade-Brittinger</name>
</author>
<author><name sortKey="Krack, P" uniqKey="Krack P">P Krack</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Okun, Ms" uniqKey="Okun M">MS Okun</name>
</author>
<author><name sortKey="Fernandez, Hh" uniqKey="Fernandez H">HH Fernandez</name>
</author>
<author><name sortKey="Wu, Ss" uniqKey="Wu S">SS Wu</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Weaver, Fm" uniqKey="Weaver F">FM Weaver</name>
</author>
<author><name sortKey="Follett, K" uniqKey="Follett K">K Follett</name>
</author>
<author><name sortKey="Stern, M" uniqKey="Stern M">M Stern</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Follett, Ka" uniqKey="Follett K">KA Follett</name>
</author>
<author><name sortKey="Weaver, Fm" uniqKey="Weaver F">FM Weaver</name>
</author>
<author><name sortKey="Stern, M" uniqKey="Stern M">M Stern</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kleiner Fisman, G" uniqKey="Kleiner Fisman G">G Kleiner-Fisman</name>
</author>
<author><name sortKey="Herzog, J" uniqKey="Herzog J">J Herzog</name>
</author>
<author><name sortKey="Fisman, Dn" uniqKey="Fisman D">DN Fisman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Volkmann, J" uniqKey="Volkmann J">J Volkmann</name>
</author>
<author><name sortKey="Allert, N" uniqKey="Allert N">N Allert</name>
</author>
<author><name sortKey="Voges, J" uniqKey="Voges J">J Voges</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Houeto, Jl" uniqKey="Houeto J">JL Houeto</name>
</author>
<author><name sortKey="Damier, P" uniqKey="Damier P">P Damier</name>
</author>
<author><name sortKey="Bejjani, Pb" uniqKey="Bejjani P">PB Bejjani</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Weaver, Fm" uniqKey="Weaver F">FM Weaver</name>
</author>
<author><name sortKey="Follett, Ka" uniqKey="Follett K">KA Follett</name>
</author>
<author><name sortKey="Stern, M" uniqKey="Stern M">M Stern</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Evidente, Vg" uniqKey="Evidente V">VG Evidente</name>
</author>
<author><name sortKey="Premkumar, Ap" uniqKey="Premkumar A">AP Premkumar</name>
</author>
<author><name sortKey="Adler, Ch" uniqKey="Adler C">CH Adler</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Moro, E" uniqKey="Moro E">E Moro</name>
</author>
<author><name sortKey="Lozano, Am" uniqKey="Lozano A">AM Lozano</name>
</author>
<author><name sortKey="Pollak, P" uniqKey="Pollak P">P Pollak</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lang, Ae" uniqKey="Lang A">AE Lang</name>
</author>
<author><name sortKey="Widner, H" uniqKey="Widner H">H Widner</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Morgante, L" uniqKey="Morgante L">L Morgante</name>
</author>
<author><name sortKey="Morgante, F" uniqKey="Morgante F">F Morgante</name>
</author>
<author><name sortKey="Moro, E" uniqKey="Moro E">E Moro</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Lang, Ae" uniqKey="Lang A">AE Lang</name>
</author>
<author><name sortKey="Houeto, Jl" uniqKey="Houeto J">JL Houeto</name>
</author>
<author><name sortKey="Krack, P" uniqKey="Krack P">P Krack</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Fox, Sh" uniqKey="Fox S">SH Fox</name>
</author>
<author><name sortKey="Katzenschlager, R" uniqKey="Katzenschlager R">R Katzenschlager</name>
</author>
<author><name sortKey="Lim, Sy" uniqKey="Lim S">SY Lim</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Koller, Wc" uniqKey="Koller W">WC Koller</name>
</author>
<author><name sortKey="Tse, W" uniqKey="Tse W">W Tse</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Poewe, W" uniqKey="Poewe W">W Poewe</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hatano, T" uniqKey="Hatano T">T Hatano</name>
</author>
<author><name sortKey="Kubo, Si" uniqKey="Kubo S">SI Kubo</name>
</author>
<author><name sortKey="Shimo, Y" uniqKey="Shimo Y">Y Shimo</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schapira, Ah" uniqKey="Schapira A">AH Schapira</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Moro, E" uniqKey="Moro E">E Moro</name>
</author>
<author><name sortKey="Lang, Ae" uniqKey="Lang A">AE Lang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bronstein, Jm" uniqKey="Bronstein J">JM Bronstein</name>
</author>
<author><name sortKey="Tagliati, M" uniqKey="Tagliati M">M Tagliati</name>
</author>
<author><name sortKey="Alterman, Rl" uniqKey="Alterman R">RL Alterman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Moro, E" uniqKey="Moro E">E Moro</name>
</author>
<author><name sortKey="Allert, N" uniqKey="Allert N">N Allert</name>
</author>
<author><name sortKey="Eleopra, R" uniqKey="Eleopra R">R Eleopra</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wachter, T" uniqKey="Wachter T">T Wachter</name>
</author>
<author><name sortKey="Minguez Castellanos, A" uniqKey="Minguez Castellanos A">A Minguez-Castellanos</name>
</author>
<author><name sortKey="Valldeoriola, F" uniqKey="Valldeoriola F">F Valldeoriola</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Krack, P" uniqKey="Krack P">P Krack</name>
</author>
<author><name sortKey="Batir, A" uniqKey="Batir A">A Batir</name>
</author>
<author><name sortKey="Van, Bn" uniqKey="Van B">BN Van</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fasano, A" uniqKey="Fasano A">A Fasano</name>
</author>
<author><name sortKey="Romito, Lm" uniqKey="Romito L">LM Romito</name>
</author>
<author><name sortKey="Daniele, A" uniqKey="Daniele A">A Daniele</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Vitek, Jl" uniqKey="Vitek J">JL Vitek</name>
</author>
<author><name sortKey="Lyons, Ke" uniqKey="Lyons K">KE Lyons</name>
</author>
<author><name sortKey="Bakay, R" uniqKey="Bakay R">R Bakay</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wider, C" uniqKey="Wider C">C Wider</name>
</author>
<author><name sortKey="Russmann, H" uniqKey="Russmann H">H Russmann</name>
</author>
<author><name sortKey="Villemure, Jg" uniqKey="Villemure J">JG Villemure</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zibetti, M" uniqKey="Zibetti M">M Zibetti</name>
</author>
<author><name sortKey="Merola, A" uniqKey="Merola A">A Merola</name>
</author>
<author><name sortKey="Rizzi, L" uniqKey="Rizzi L">L Rizzi</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Castrioto, A" uniqKey="Castrioto A">A Castrioto</name>
</author>
<author><name sortKey="Lozano, Am" uniqKey="Lozano A">AM Lozano</name>
</author>
<author><name sortKey="Poon, Yy" uniqKey="Poon Y">YY Poon</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Follett, Ka" uniqKey="Follett K">KA Follett</name>
</author>
<author><name sortKey="Torres Russotto, D" uniqKey="Torres Russotto D">D Torres-Russotto</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hariz, Mi" uniqKey="Hariz M">MI Hariz</name>
</author>
<author><name sortKey="Krack, P" uniqKey="Krack P">P Krack</name>
</author>
<author><name sortKey="Alesch, F" uniqKey="Alesch F">F Alesch</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fimm, B" uniqKey="Fimm B">B Fimm</name>
</author>
<author><name sortKey="Heber, Ia" uniqKey="Heber I">IA Heber</name>
</author>
<author><name sortKey="Coenen, Va" uniqKey="Coenen V">VA Coenen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Halpern, Ch" uniqKey="Halpern C">CH Halpern</name>
</author>
<author><name sortKey="Rick, Jh" uniqKey="Rick J">JH Rick</name>
</author>
<author><name sortKey="Danish, Sf" uniqKey="Danish S">SF Danish</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nazzaro, Jm" uniqKey="Nazzaro J">JM Nazzaro</name>
</author>
<author><name sortKey="Pahwa, R" uniqKey="Pahwa R">R Pahwa</name>
</author>
<author><name sortKey="Lyons, Ke" uniqKey="Lyons K">KE Lyons</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Strutt, Am" uniqKey="Strutt A">AM Strutt</name>
</author>
<author><name sortKey="Simpson, R" uniqKey="Simpson R">R Simpson</name>
</author>
<author><name sortKey="Jankovic, J" uniqKey="Jankovic J">J Jankovic</name>
</author>
<author><name sortKey="York, Mk" uniqKey="York M">MK York</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Halim, A" uniqKey="Halim A">A Halim</name>
</author>
<author><name sortKey="Baumgartner, L" uniqKey="Baumgartner L">L Baumgartner</name>
</author>
<author><name sortKey="Binder, Dk" uniqKey="Binder D">DK Binder</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Witjas, T" uniqKey="Witjas T">T Witjas</name>
</author>
<author><name sortKey="Kaphan, E" uniqKey="Kaphan E">E Kaphan</name>
</author>
<author><name sortKey="Regis, J" uniqKey="Regis J">J Regis</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="St George, Rj" uniqKey="St George R">RJ St George</name>
</author>
<author><name sortKey="Carlson Kuhta, P" uniqKey="Carlson Kuhta P">P Carlson-Kuhta</name>
</author>
<author><name sortKey="Burchiel, Kj" uniqKey="Burchiel K">KJ Burchiel</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Rothlind, Jc" uniqKey="Rothlind J">JC Rothlind</name>
</author>
<author><name sortKey="Cockshott, Rw" uniqKey="Cockshott R">RW Cockshott</name>
</author>
<author><name sortKey="Starr, Pa" uniqKey="Starr P">PA Starr</name>
</author>
<author><name sortKey="Marks, Wj" uniqKey="Marks W">WJ Marks</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zahodne, Lb" uniqKey="Zahodne L">LB Zahodne</name>
</author>
<author><name sortKey="Okun, Ms" uniqKey="Okun M">MS Okun</name>
</author>
<author><name sortKey="Foote, Kd" uniqKey="Foote K">KD Foote</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Chan, Dt" uniqKey="Chan D">DT Chan</name>
</author>
<author><name sortKey="Zhu, Xl" uniqKey="Zhu X">XL Zhu</name>
</author>
<author><name sortKey="Yeung, Jh" uniqKey="Yeung J">JH Yeung</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Voon, V" uniqKey="Voon V">V Voon</name>
</author>
<author><name sortKey="Krack, P" uniqKey="Krack P">P Krack</name>
</author>
<author><name sortKey="Lang, Ae" uniqKey="Lang A">AE Lang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kirsch Darrow, L" uniqKey="Kirsch Darrow L">L Kirsch-Darrow</name>
</author>
<author><name sortKey="Zahodne, Lb" uniqKey="Zahodne L">LB Zahodne</name>
</author>
<author><name sortKey="Marsiske, M" uniqKey="Marsiske M">M Marsiske</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Porat, O" uniqKey="Porat O">O Porat</name>
</author>
<author><name sortKey="Cohen, Os" uniqKey="Cohen O">OS Cohen</name>
</author>
<author><name sortKey="Schwartz, R" uniqKey="Schwartz R">R Schwartz</name>
</author>
<author><name sortKey="Hassin Baer, S" uniqKey="Hassin Baer S">S Hassin-Baer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Witt, K" uniqKey="Witt K">K Witt</name>
</author>
<author><name sortKey="Daniels, C" uniqKey="Daniels C">C Daniels</name>
</author>
<author><name sortKey="Reiff, J" uniqKey="Reiff J">J Reiff</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Peron, J" uniqKey="Peron J">J Peron</name>
</author>
<author><name sortKey="Biseul, I" uniqKey="Biseul I">I Biseul</name>
</author>
<author><name sortKey="Leray, E" uniqKey="Leray E">E Leray</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Demetriades, P" uniqKey="Demetriades P">P Demetriades</name>
</author>
<author><name sortKey="Rickards, H" uniqKey="Rickards H">H Rickards</name>
</author>
<author><name sortKey="Cavanna, Ae" uniqKey="Cavanna A">AE Cavanna</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Broen, M" uniqKey="Broen M">M Broen</name>
</author>
<author><name sortKey="Duits, A" uniqKey="Duits A">A Duits</name>
</author>
<author><name sortKey="Visser Vandewalle, V" uniqKey="Visser Vandewalle V">V Visser-Vandewalle</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Appleby, Bs" uniqKey="Appleby B">BS Appleby</name>
</author>
<author><name sortKey="Duggan, Ps" uniqKey="Duggan P">PS Duggan</name>
</author>
<author><name sortKey="Regenberg, A" uniqKey="Regenberg A">A Regenberg</name>
</author>
<author><name sortKey="Rabins, Pv" uniqKey="Rabins P">PV Rabins</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Heo, Jh" uniqKey="Heo J">JH Heo</name>
</author>
<author><name sortKey="Lee, Km" uniqKey="Lee K">KM Lee</name>
</author>
<author><name sortKey="Paek, Sh" uniqKey="Paek S">SH Paek</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Alberts, Jl" uniqKey="Alberts J">JL Alberts</name>
</author>
<author><name sortKey="Voelcker Rehage, C" uniqKey="Voelcker Rehage C">C Voelcker-Rehage</name>
</author>
<author><name sortKey="Hallahan, K" uniqKey="Hallahan K">K Hallahan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Thobois, S" uniqKey="Thobois S">S Thobois</name>
</author>
<author><name sortKey="Ardouin, C" uniqKey="Ardouin C">C Ardouin</name>
</author>
<author><name sortKey="Lhommee, E" uniqKey="Lhommee E">E Lhommée</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Videnovic, A" uniqKey="Videnovic A">A Videnovic</name>
</author>
<author><name sortKey="Metman, Lv" uniqKey="Metman L">LV Metman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Amara, Aw" uniqKey="Amara A">AW Amara</name>
</author>
<author><name sortKey="Watts, Rl" uniqKey="Watts R">RL Watts</name>
</author>
<author><name sortKey="Walker, Hc" uniqKey="Walker H">HC Walker</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shields, Dc" uniqKey="Shields D">DC Shields</name>
</author>
<author><name sortKey="Lam, S" uniqKey="Lam S">S Lam</name>
</author>
<author><name sortKey="Gorgulho, A" uniqKey="Gorgulho A">A Gorgulho</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Doshi, P" uniqKey="Doshi P">P Doshi</name>
</author>
<author><name sortKey="Bhargava, P" uniqKey="Bhargava P">P Bhargava</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Okun, Ms" uniqKey="Okun M">MS Okun</name>
</author>
<author><name sortKey="Gallo, Bv" uniqKey="Gallo B">BV Gallo</name>
</author>
<author><name sortKey="Mandybur, G" uniqKey="Mandybur G">G Mandybur</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Derost, Pp" uniqKey="Derost P">PP Derost</name>
</author>
<author><name sortKey="Ouchchane, L" uniqKey="Ouchchane L">L Ouchchane</name>
</author>
<author><name sortKey="Morand, D" uniqKey="Morand D">D Morand</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Williams, A" uniqKey="Williams A">A Williams</name>
</author>
<author><name sortKey="Gill, S" uniqKey="Gill S">S Gill</name>
</author>
<author><name sortKey="Varma, T" uniqKey="Varma T">T Varma</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Dams, J" uniqKey="Dams J">J Dams</name>
</author>
<author><name sortKey="Bornschein, B" uniqKey="Bornschein B">B Bornschein</name>
</author>
<author><name sortKey="Reese, Jp" uniqKey="Reese J">JP Reese</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Mcintosh, E" uniqKey="Mcintosh E">E McIntosh</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Valldeoriola, F" uniqKey="Valldeoriola F">F Valldeoriola</name>
</author>
<author><name sortKey="Morsi, O" uniqKey="Morsi O">O Morsi</name>
</author>
<author><name sortKey="Tolosa, E" uniqKey="Tolosa E">E Tolosa</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Spottke, Ea" uniqKey="Spottke E">EA Spottke</name>
</author>
<author><name sortKey="Volkmann, J" uniqKey="Volkmann J">J Volkmann</name>
</author>
<author><name sortKey="Lorenz, D" uniqKey="Lorenz D">D Lorenz</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fraix, V" uniqKey="Fraix V">V Fraix</name>
</author>
<author><name sortKey="Houeto, Jl" uniqKey="Houeto J">JL Houeto</name>
</author>
<author><name sortKey="Lagrange, C" uniqKey="Lagrange C">C Lagrange</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kahn, E" uniqKey="Kahn E">E Kahn</name>
</author>
<author><name sortKey="D Haese, Pf" uniqKey="D Haese P">PF D'Haese</name>
</author>
<author><name sortKey="Dawant, B" uniqKey="Dawant B">B Dawant</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schupbach, Wm" uniqKey="Schupbach W">WM Schupbach</name>
</author>
<author><name sortKey="Maltete, D" uniqKey="Maltete D">D Maltete</name>
</author>
<author><name sortKey="Houeto, Jl" uniqKey="Houeto J">JL Houeto</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Agid, Y" uniqKey="Agid Y">Y Agid</name>
</author>
<author><name sortKey="Schupbach, M" uniqKey="Schupbach M">M Schupbach</name>
</author>
<author><name sortKey="Gargiulo, M" uniqKey="Gargiulo M">M Gargiulo</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Okun, Ms" uniqKey="Okun M">MS Okun</name>
</author>
<author><name sortKey="Wu, Ss" uniqKey="Wu S">SS Wu</name>
</author>
<author><name sortKey="Foote, Kd" uniqKey="Foote K">KD Foote</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Yamada, K" uniqKey="Yamada K">K Yamada</name>
</author>
<author><name sortKey="Hamasaki, T" uniqKey="Hamasaki T">T Hamasaki</name>
</author>
<author><name sortKey="Kuratsu, J" uniqKey="Kuratsu J">J Kuratsu</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Deuschl, G" uniqKey="Deuschl G">G Deuschl</name>
</author>
<author><name sortKey="Schupbach, M" uniqKey="Schupbach M">M Schüpbach</name>
</author>
<author><name sortKey="Knudsen, K" uniqKey="Knudsen K">K Knudsen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schuepbach, Wmm" uniqKey="Schuepbach W">WMM Schuepbach</name>
</author>
<author><name sortKey="Rau, J" uniqKey="Rau J">J Rau</name>
</author>
<author><name sortKey="Knudsen, K" uniqKey="Knudsen K">K Knudsen</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Espay, Aj" uniqKey="Espay A">AJ Espay</name>
</author>
<author><name sortKey="Vaughan, Je" uniqKey="Vaughan J">JE Vaughan</name>
</author>
<author><name sortKey="Marras, C" uniqKey="Marras C">C Marras</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Merola, A" uniqKey="Merola A">A Merola</name>
</author>
<author><name sortKey="Zibetti, M" uniqKey="Zibetti M">M Zibetti</name>
</author>
<author><name sortKey="Artusi, Ca" uniqKey="Artusi C">CA Artusi</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Olanow, Cw" uniqKey="Olanow C">CW Olanow</name>
</author>
<author><name sortKey="Kieburtz, K" uniqKey="Kieburtz K">K Kieburtz</name>
</author>
<author><name sortKey="Schapira, Ah" uniqKey="Schapira A">AH Schapira</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Obeso, Ja" uniqKey="Obeso J">JA Obeso</name>
</author>
<author><name sortKey="Rodriguez Oroz, Mc" uniqKey="Rodriguez Oroz M">MC Rodriguez-Oroz</name>
</author>
<author><name sortKey="Goetz, Cg" uniqKey="Goetz C">CG Goetz</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schapira, Ah" uniqKey="Schapira A">AH Schapira</name>
</author>
<author><name sortKey="Tolosa, E" uniqKey="Tolosa E">E Tolosa</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Spieles Engemann, Al" uniqKey="Spieles Engemann A">AL Spieles-Engemann</name>
</author>
<author><name sortKey="Behbehani, Mm" uniqKey="Behbehani M">MM Behbehani</name>
</author>
<author><name sortKey="Collier, Tj" uniqKey="Collier T">TJ Collier</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Maesawa, S" uniqKey="Maesawa S">S Maesawa</name>
</author>
<author><name sortKey="Kaneoke, Y" uniqKey="Kaneoke Y">Y Kaneoke</name>
</author>
<author><name sortKey="Kajita, Y" uniqKey="Kajita Y">Y Kajita</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Harnack, D" uniqKey="Harnack D">D Harnack</name>
</author>
<author><name sortKey="Meissner, W" uniqKey="Meissner W">W Meissner</name>
</author>
<author><name sortKey="Jira, Ja" uniqKey="Jira J">JA Jira</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Carvalho, Ga" uniqKey="Carvalho G">GA Carvalho</name>
</author>
<author><name sortKey="Nikkhah, G" uniqKey="Nikkhah G">G Nikkhah</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Zhao, Xd" uniqKey="Zhao X">XD Zhao</name>
</author>
<author><name sortKey="Cao, Yq" uniqKey="Cao Y">YQ Cao</name>
</author>
<author><name sortKey="Liu, Hh" uniqKey="Liu H">HH Liu</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wallace, Ba" uniqKey="Wallace B">BA Wallace</name>
</author>
<author><name sortKey="Ashkan, K" uniqKey="Ashkan K">K Ashkan</name>
</author>
<author><name sortKey="Heise, Ce" uniqKey="Heise C">CE Heise</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shaw, Ve" uniqKey="Shaw V">VE Shaw</name>
</author>
<author><name sortKey="Keay, Ka" uniqKey="Keay K">KA Keay</name>
</author>
<author><name sortKey="Ashkan, K" uniqKey="Ashkan K">K Ashkan</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Charles, Pd" uniqKey="Charles P">PD Charles</name>
</author>
<author><name sortKey="Gill, Ce" uniqKey="Gill C">CE Gill</name>
</author>
<author><name sortKey="Davis, Tl" uniqKey="Davis T">TL Davis</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wichmann, T" uniqKey="Wichmann T">T Wichmann</name>
</author>
<author><name sortKey="Delong, Mr" uniqKey="Delong M">MR DeLong</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Wichmann, T" uniqKey="Wichmann T">T Wichmann</name>
</author>
<author><name sortKey="Bergman, H" uniqKey="Bergman H">H Bergman</name>
</author>
<author><name sortKey="Delong, Mr" uniqKey="Delong M">MR DeLong</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lin, Tp" uniqKey="Lin T">TP Lin</name>
</author>
<author><name sortKey="Carbon, M" uniqKey="Carbon M">M Carbon</name>
</author>
<author><name sortKey="Tang, C" uniqKey="Tang C">C Tang</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Eckert, T" uniqKey="Eckert T">T Eckert</name>
</author>
<author><name sortKey="Tang, C" uniqKey="Tang C">C Tang</name>
</author>
<author><name sortKey="Eidelberg, D" uniqKey="Eidelberg D">D Eidelberg</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Asanuma, K" uniqKey="Asanuma K">K Asanuma</name>
</author>
<author><name sortKey="Tang, C" uniqKey="Tang C">C Tang</name>
</author>
<author><name sortKey="Ma, Y" uniqKey="Ma Y">Y Ma</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Amtage, F" uniqKey="Amtage F">F Amtage</name>
</author>
<author><name sortKey="Henschel, K" uniqKey="Henschel K">K Henschel</name>
</author>
<author><name sortKey="Schelter, B" uniqKey="Schelter B">B Schelter</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Schapira, Ah" uniqKey="Schapira A">AH Schapira</name>
</author>
<author><name sortKey="Obeso, J" uniqKey="Obeso J">J Obeso</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Warnke, Pc" uniqKey="Warnke P">PC Warnke</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hilker, R" uniqKey="Hilker R">R Hilker</name>
</author>
<author><name sortKey="Portman, At" uniqKey="Portman A">AT Portman</name>
</author>
<author><name sortKey="Voges, J" uniqKey="Voges J">J Voges</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nimura, T" uniqKey="Nimura T">T Nimura</name>
</author>
<author><name sortKey="Yamaguchi, K" uniqKey="Yamaguchi K">K Yamaguchi</name>
</author>
<author><name sortKey="Ando, T" uniqKey="Ando T">T Ando</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Temperli, P" uniqKey="Temperli P">P Temperli</name>
</author>
<author><name sortKey="Ghika, J" uniqKey="Ghika J">J Ghika</name>
</author>
<author><name sortKey="Villemure, Jg" uniqKey="Villemure J">JG Villemure</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hariz, Mi" uniqKey="Hariz M">MI Hariz</name>
</author>
<author><name sortKey="Johansson, F" uniqKey="Johansson F">F Johansson</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Fahn, S" uniqKey="Fahn S">S Fahn</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hilker, R" uniqKey="Hilker R">R Hilker</name>
</author>
<author><name sortKey="Voges, J" uniqKey="Voges J">J Voges</name>
</author>
<author><name sortKey="Weisenbach, S" uniqKey="Weisenbach S">S Weisenbach</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Kalbe, E" uniqKey="Kalbe E">E Kalbe</name>
</author>
<author><name sortKey="Voges, J" uniqKey="Voges J">J Voges</name>
</author>
<author><name sortKey="Weber, T" uniqKey="Weber T">T Weber</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hely, Ma" uniqKey="Hely M">MA Hely</name>
</author>
<author><name sortKey="Reid, Wg" uniqKey="Reid W">WG Reid</name>
</author>
<author><name sortKey="Adena, Ma" uniqKey="Adena M">MA Adena</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Obeso, Ja" uniqKey="Obeso J">JA Obeso</name>
</author>
<author><name sortKey="Olanow, W" uniqKey="Olanow W">W Olanow</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hamani, C" uniqKey="Hamani C">C Hamani</name>
</author>
<author><name sortKey="Richter, E" uniqKey="Richter E">E Richter</name>
</author>
<author><name sortKey="Schwalb, Jm" uniqKey="Schwalb J">JM Schwalb</name>
</author>
<author><name sortKey="Lozano, Am" uniqKey="Lozano A">AM Lozano</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Shichi, T" uniqKey="Shichi T">T Shichi</name>
</author>
<author><name sortKey="Okiyama, R" uniqKey="Okiyama R">R Okiyama</name>
</author>
<author><name sortKey="Yokochi, F" uniqKey="Yokochi F">F Yokochi</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Neurol</journal-id>
<journal-id journal-id-type="publisher-id">ana</journal-id>
<journal-title-group><journal-title>Annals of Neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0364-5134</issn>
<issn pub-type="epub">1531-8249</issn>
<publisher><publisher-name>BlackWell Publishing Ltd</publisher-name>
<publisher-loc>Oxford, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">23483564</article-id>
<article-id pub-id-type="pmc">4065356</article-id>
<article-id pub-id-type="doi">10.1002/ana.23890</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Point of View</subject>
</subj-group>
</article-categories>
<title-group><article-title>Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>deSouza</surname>
<given-names>Ruth-Mary</given-names>
</name>
<degrees>MRCS</degrees>
<xref ref-type="aff" rid="au1">1</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Moro</surname>
<given-names>Elena</given-names>
</name>
<degrees>PhD, MD</degrees>
<xref ref-type="aff" rid="au2">2</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Lang</surname>
<given-names>Anthony E</given-names>
</name>
<degrees>FRCP, MD</degrees>
<xref ref-type="aff" rid="au3">3</xref>
</contrib>
<contrib contrib-type="author"><name><surname>Schapira</surname>
<given-names>Anthony H V</given-names>
</name>
<degrees>DSc, MD, FRCP, FMedSci</degrees>
<xref ref-type="aff" rid="au1">1</xref>
</contrib>
<aff id="au1"><label>1</label>
<institution>Department of Clinical Neurosciences, Institute of Neurology, University College London</institution>
<addr-line>London, United Kingdom</addr-line>
</aff>
<aff id="au2"><label>2</label>
<institution>Movement Disorders Center, Department of Psychiatry and Neurology, University Hospital Center of Grenoble</institution>
<addr-line>Grenoble, France</addr-line>
</aff>
<aff id="au3"><label>3</label>
<institution>Toronto Western Hospital</institution>
<addr-line>Toronto, Ontario, Canada</addr-line>
</aff>
</contrib-group>
<author-notes><corresp id="cor1">Address correspondence to Dr Schapira, Head of Department of Clinical Neurosciences, UCL Institute of Neurology, Rowland Hill St, London NW3 2PF, United Kingdom. E-mail: <email>a.schapira@ucl.ac.uk</email>
.</corresp>
</author-notes>
<pub-date pub-type="ppub"><month>5</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub"><day>28</day>
<month>5</month>
<year>2013</year>
</pub-date>
<volume>73</volume>
<issue>5</issue>
<fpage>565</fpage>
<lpage>575</lpage>
<history><date date-type="received"><day>13</day>
<month>7</month>
<year>2012</year>
</date>
<date date-type="rev-recd"><day>28</day>
<month>2</month>
<year>2013</year>
</date>
<date date-type="accepted"><day>01</day>
<month>3</month>
<year>2013</year>
</date>
</history>
<permissions><copyright-statement>© 2013 American Neurological Association</copyright-statement>
<copyright-year>2013</copyright-year>
</permissions>
<abstract><p>We review the current application of deep brain stimulation (DBS) in Parkinson disease (PD) and consider the evidence that earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy.</p>
<p>Electronic searches were performed of PubMed, Web of Knowledge, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials to identify all article types relating to the timing of DBS in PD.</p>
<p>Current evidence suggests that DBS is typically performed in late stage PD, a mean of 14 to 15 years after diagnosis. Current guidelines recommend that PD patients who are resistant to medical therapies, have significant medication side effects and lengthening off periods, but are otherwise cognitively intact and medically fit for surgery be considered for DBS.</p>
<p>If these criteria are rigidly interpreted, it may be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit for neurosurgical intervention. From the evidence available, we conclude that surgical management of PD alone or in combination with medical therapy results in greater improvement of motor symptoms and quality of life than medical treatment alone. There is evidence to support the use of DBS in less advanced PD and that it may be appropriate for earlier stages of the disease than for which it is currently used. The improving short and long-term safety profile of DBS makes early application a realistic possibility. Ann Neurol 2013;73:565–575</p>
</abstract>
</article-meta>
</front>
<body><p>Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease. The incidence rate of PD is 12 to 20 per 100,000 annually in Northern Europe.<xref rid="b1" ref-type="bibr">1</xref>
 It is estimated that there are approximately 1 million PD sufferers in the USA and 120,000 in the United Kingdom, 1 in 20 of whom are under the age of 40 years.<xref rid="b2" ref-type="bibr">2</xref>
 An analysis of PD epidemiology suggests that the number of individuals aged >50 years with PD in the world's most populated countries will approximately double to between 8.7 and 9.3 million in 2030.<xref rid="b3" ref-type="bibr">3</xref>
</p>
<p>In 2007, the global economic cost of PD was estimated to be up to £3 billion (approximately US $4.63 billion) annually.<xref rid="b4" ref-type="bibr">4</xref>
 Recent reviews and cost analyses showed the greatest expenditure was on nursing homes and social care.<xref rid="b5" ref-type="bibr">5</xref>
–<xref rid="b7" ref-type="bibr">7</xref>
 Costs increase in later stage PD.<xref rid="b8" ref-type="bibr">8</xref>
 This reinforces the notion that despite optimal medical therapy, there remains significant morbidity and disability yet to be addressed in PD.</p>
<p>The clinical features of PD comprise the well-recognized motor syndrome and a large number of nonmotor manifestations.<xref rid="b9" ref-type="bibr">9</xref>
 Medication side effects, psychological morbidity, poor quality of life, and the burden on carers are important components that make PD a complex, chronic, multifaceted disease.</p>
<p>The mainstay of treatment for PD is currently medical, surgical, and supportive treatment. Among surgical treatments, there is currently level 1 evidence that deep brain stimulation (DBS) of the subthalamic nucleus (STN) and the globus pallidus internus (GPi) is effective in improving L-dopa–responsive signs in PD patients.<xref rid="b10" ref-type="bibr">10</xref>
–<xref rid="b13" ref-type="bibr">13</xref>
 Traditionally, DBS has been typically left until late stage PD, a mean of 14 to 15 years after diagnosis,<xref rid="b14" ref-type="bibr">14</xref>
–<xref rid="b16" ref-type="bibr">16</xref>
 although this may not necessarily reflect current practice. Continued interest in surgical therapies for PD is encouraged by the increasing awareness of the adverse effects and limitations of medical therapy for PD as well as advances in medical imaging and bioengineering technology. STN DBS received US Food and Drug Administration approval for use in PD in 2002 and GPi DBS received it in 2003. Work then centered on finding the ideal nucleus to target.<xref rid="b13" ref-type="bibr">13</xref>
–<xref rid="b19" ref-type="bibr">19</xref>
</p>
<p>The initial criteria of inclusion for DBS have been relatively strict and include the presence of significant disability but the absence of cognitive dysfunction.<xref rid="b20" ref-type="bibr">20</xref>
,<xref rid="b21" ref-type="bibr">21</xref>
 The UK National Institute for Clinical Excellence (NICE) guidelines have recommended that PD patients who are resistant to medical therapies, have severe medication side effects and lengthening off periods, but are medically and psychologically fit for surgery, be considered for DBS.<xref rid="b22" ref-type="bibr">22</xref>
 If these criteria are rigidly interpreted, it might be that, by the time medical treatment options have been exhausted, the disease has progressed to the point that the patient may no longer be fit enough for neurosurgical intervention. The 2006 consensus on treatments for PD acknowledged this potentially critical issue in patient selection, proposing individualized criteria for selection (disability, quality of life, expectations of functionality, interpersonal relationships), good response to L-dopa (the only positive predictor of DBS benefit), and recommended further research into the use of surgery earlier in the course of PD.<xref rid="b23" ref-type="bibr">23</xref>
</p>
<p>The purpose of this review is to consider whether earlier use of DBS confers long-term symptomatic benefit for patients compared to best medical therapy, and to review the evidence suggesting DBS has a disease-modifying role.</p>
<sec><title>Current Medical Management of PD</title>
<p>Following a diagnosis of PD, NICE considers the management in 3 main tiers: management of early PD (functional effect of disease apparent), management of late PD (motor complications), and surgical management.<xref rid="b24" ref-type="bibr">24</xref>
 The Movement Disorder Society also used critical appraisal of the literature to offer guidelines on management of uncomplicated and complicated PD.<xref rid="b25" ref-type="bibr">25</xref>
 Combination therapy is recognized to be a common feature at all stages. The unmet needs of PD management include control of nonmotor features, motor complications, and the development of disease-modifying therapies.<xref rid="b26" ref-type="bibr">26</xref>
–<xref rid="b29" ref-type="bibr">29</xref>
 Currently, medical therapy remains the first-line treatment for PD, and DBS should only be considered for selected patients in whom medical therapy is failing and its effectiveness is limited by side effects.</p>
</sec>
<sec><title>Current Use of DBS in PD</title>
<p>The current indications and patient selection criteria for DBS have recently been reviewed.<xref rid="b23" ref-type="bibr">23</xref>
,<xref rid="b30" ref-type="bibr">30</xref>
,<xref rid="b31" ref-type="bibr">31</xref>
 For DBS to be considered, most importantly the patient must have dopamine-responsive PD. The patient should not have significant cognitive dysfunction, and should be emotionally stable with no active severe psychiatric symptoms. Both sporadic and genetic PD patients are eligible for DBS.<xref rid="b30" ref-type="bibr">30</xref>
</p>
<p>Because cognitive, affective, and psychotic symptoms are part of the (late) natural history of PD and medical comorbidities increase with age and debility, it is possible that by waiting too long to perform DBS we are turning potential DBS candidates into exclusion cases.<xref rid="b32" ref-type="bibr">32</xref>
,<xref rid="b33" ref-type="bibr">33</xref>
</p>
<p>The benefits of DBS include motor and nonmotor function attenuation of drug-induced dyskinesias and improvement in quality of life.<xref rid="b10" ref-type="bibr">10</xref>
,<xref rid="b16" ref-type="bibr">16</xref>
,<xref rid="b34" ref-type="bibr">34</xref>
,<xref rid="b35" ref-type="bibr">35</xref>
</p>
<p>In terms of motor benefits, DBS reduces off symptoms by 60%, rapidly reduces medication-induced dyskinesias in STN DBS by 60 to 80% as medication requirements are less, and improves Unified Parkinson Disease Rating Scale (UPDRS) scores and self-assessed quality of life.<xref rid="b10" ref-type="bibr">10</xref>
,<xref rid="b15" ref-type="bibr">15</xref>
,<xref rid="b34" ref-type="bibr">34</xref>
 Although many claims have been made regarding the relative benefits of STN versus GPi stimulation, only well-designed studies with homogeneous reporting methods of outcomes will enable robust discrimination of benefit between different DBS sites and techniques.<xref rid="b36" ref-type="bibr">36</xref>
 STN DBS was shown in a level 3 study of 30 patients to be associated with maintenance of the long-term L-dopa response but worsening of the short-term L-dopa response in advanced PD, a situation mimicking early stage PD.<xref rid="b37" ref-type="bibr">37</xref>
 Long-term data are now emerging, and indicate that DBS motor benefits are still clinically apparent at 10 years.<xref rid="b19" ref-type="bibr">19</xref>
,<xref rid="b38" ref-type="bibr">38</xref>
,<xref rid="b39" ref-type="bibr">39</xref>
 The 10-year follow-up of 18 patients showed that STN DBS resulted in significant improvement in tremor, bradykinesia, and total motor score but not axial motor function and not activities of daily living (ADL) scores.<xref rid="b39" ref-type="bibr">39</xref>
 There are studies comparing STN and GPi DBS in terms of long-term benefit. A 5-year prospective study of 35 STN patients and 16 GPi patients showed STN DBS to be associated with greater motor benefit than GPi DBS in some domains (off-medication UPDRS, dyskinesias, and ADL).<xref rid="b19" ref-type="bibr">19</xref>
 A randomized trial of 159 patients with PD showed significant improvements in 36-month motor UPDRS on-stimulation/on-medication and off-stimulation/off-medication, both of which favored GPi, but there was no difference in overall quality of life measures at this time point, although dementia rating scales declined faster in the STN group.<xref rid="b17" ref-type="bibr">17</xref>
 This study also showed stability of benefits at 3 years.<xref rid="b17" ref-type="bibr">17</xref>
 The COMPARE trial examined the effects of GPi versus STN DBS on cognition and mood in 45 patients with a mean PD duration of 13 years.<xref rid="b11" ref-type="bibr">11</xref>
 No overall difference was observed between the groups, but verbal fluency was worse at 7 months after STN than GPi DBS.<xref rid="b11" ref-type="bibr">11</xref>
 Both STN and GPi DBS offer advantages,<xref rid="b40" ref-type="bibr">40</xref>
 and the differences between these may only become apparent in studies with >5 years follow-up postimplantation.<xref rid="b19" ref-type="bibr">19</xref>
,<xref rid="b31" ref-type="bibr">31</xref>
,<xref rid="b34" ref-type="bibr">34</xref>
,<xref rid="b41" ref-type="bibr">41</xref>
 Studies addressing the effect of DBS on symptoms also report improvement of nonmotor features of PD such as pain, akathisia, cognitive function, emotion, ADL, and autonomic function.<xref rid="b42" ref-type="bibr">42</xref>
–<xref rid="b47" ref-type="bibr">47</xref>
</p>
<p>The choice between STN and GPi DBS and whether unilateral, bilateral, or staged bilateral is based upon the patient's individual symptoms and the surgeon's experience. There is no level 1 evidence that demonstrates superiority of either site. There is level 2 and 3 evidence showing that choice and laterality of site can affect individual motor and nonmotor features (for example postural response, verbal fluency, and quality of life), but no evidence to generate firm recommendations on situations where STN or GPi would be more effective. A 6-year multicenter follow-up study showed no difference in efficacy between STN and GPi, but did show a lower incidence of DBS complications in the GPi group.<xref rid="b19" ref-type="bibr">19</xref>
,<xref rid="b48" ref-type="bibr">48</xref>
–<xref rid="b50" ref-type="bibr">50</xref>
</p>
<p>The adverse events associated with DBS are a key consideration in whether to perform this procedure more liberally. Side effects can be operation, hardware, or stimulation related (Table<xref ref-type="table" rid="tbl1">1</xref>
).<xref rid="b51" ref-type="bibr">51</xref>
 They can be immediate, early, or delayed and be motor or nonmotor. The incidence of complications is lower in large centers that specialize in DBS.<xref rid="b51" ref-type="bibr">51</xref>
</p>
<table-wrap id="tbl1" position="float"><label>TABLE 1</label>
<caption><p>Complications of DBS</p>
</caption>
<table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">Operation related</td>
<td align="left" rowspan="1" colspan="1">Intracerebral hematoma, 0–10% Chronic subdural hematoma Incorrect placement of electrodes or leads Air embolism Death, 0–4.4% Complications of anesthesia Infection (most common complication), up to 15%<xref rid="b31" ref-type="bibr">31</xref>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Hardware related</td>
<td align="left" rowspan="1" colspan="1">Interaction with cardiac pacemakers<xref rid="b112" ref-type="bibr">112</xref>
 Electrode migration, 0–19%<xref rid="b10" ref-type="bibr">10</xref>
 Lead fracture, 0–15% Lead erosion, 1–2.5% Foreign body reaction Skin erosion Interaction with diathermy causing tissue damage Cognitive decline</td>
</tr>
<tr><td align="left" colspan="2" rowspan="1"><hr></hr>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Stimulation related</td>
<td align="left" rowspan="1" colspan="1">Psychiatric disturbance including mania, depression, impulse control disorders, psychosis, and suicidal ideation Weight gain Sensory disturbance Speech, visual, and auditory disorders including apraxia of eyelid opening Dyskinesias and dystonia Reduction in verbal fluency</td>
</tr>
</tbody>
</table>
<table-wrap-foot><fn><p>Percentages are provided where available. See text for details.</p>
</fn>
<fn><p>DBS = deep brain stimulation; MRI = magnetic resonance imaging.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>From a 2011 consensus on DBS in PD, the most common surgical complications reported in the available literature were infection (0–15%), bleeding (0–10%), stroke (0–2%), lead erosion (1–2.5%), lead breakage (0–15%), lead migration (0–19%), and death (0–4.4%).<xref rid="b30" ref-type="bibr">30</xref>
 Hardware complications may necessitate a second procedure. Neuropsychiatric adverse effects reported include severe depression, increased suicide risk,<xref rid="b52" ref-type="bibr">52</xref>
 apathy, anxiety,<xref rid="b53" ref-type="bibr">53</xref>
,<xref rid="b54" ref-type="bibr">54</xref>
 decreased frontal cognitive function,<xref rid="b55" ref-type="bibr">55</xref>
 obsessive–compulsive disorder, impulse control disorders, and aggression.<xref rid="b56" ref-type="bibr">56</xref>
–<xref rid="b60" ref-type="bibr">60</xref>
 Recent data suggest bilateral STN stimulation might be associated with some worsening of motor and cognitive performance on complex dual task testing, whereas unilateral STN stimulation would not cause this problem.<xref rid="b61" ref-type="bibr">61</xref>
 Recent work, investigating the mechanisms of psychiatric symptoms post-DBS using [11C]-raclopride positron emission tomography (PET) scans of 12 patient with post–STN-DBS apathy, suggests that this symptom is associated with dopamine denervation in the mesolimbic circuits,<xref rid="b62" ref-type="bibr">62</xref>
 and apathy may be related at least in part to anti-PD drug reduction and withdrawal after surgery, rather than the direct effect of STN DBS. Other DBS-related possible complications in PD include weight gain<xref rid="b63" ref-type="bibr">63</xref>
; sleep disorders<xref rid="b64" ref-type="bibr">64</xref>
; eyelid opening apraxia<xref rid="b65" ref-type="bibr">65</xref>
; speech, gait, and balance worsening; and hypersexuality.<xref rid="b66" ref-type="bibr">66</xref>
 As indicated above, impaired verbal fluency is a known side effect of DBS<xref rid="b11" ref-type="bibr">11</xref>
 and may be a surgical effect.<xref rid="b67" ref-type="bibr">67</xref>
 Clinical effectiveness of DBS may not translate into a quality of life benefit in older patients.<xref rid="b68" ref-type="bibr">68</xref>
 DBS in a younger population seems to have a higher impact on improving their quality of life and helping to maintain active, independent lifestyles. It is possible that the incidence of serious adverse events during DBS will be less in patients with milder PD, who are likely to be younger with fewer comorbidities.</p>
</sec>
<sec><title>Evidence Comparing DBS and Medical Treatments</title>
<p>There have been a number of trials comparing optimal medical management and DBS (with or without concurrent medical management). Three randomized controlled trials show that STN DBS results in improved patient-reported quality of life.<xref rid="b10" ref-type="bibr">10</xref>
,<xref rid="b12" ref-type="bibr">12</xref>
,<xref rid="b69" ref-type="bibr">69</xref>
 Significant motor and consequent functional improvement was demonstrated by surgical patients experiencing greater improvement in UPDRS scores at 6 months post-DBS than medically managed patients in a randomized pairs trial of 156 patients who had been on L-dopa for a mean of 13 years.<xref rid="b10" ref-type="bibr">10</xref>
 The PD SURG randomized open label trial compared best medical therapy and surgery (either stimulation or lesioning of the STN or the GPi). This randomized controlled trial of bilateral DBS versus medical therapy evaluated 255 patients who had taken PD medications for a mean of 10 to 12 years. After 6 months of follow-up, those who had DBS showed significant improvement in motor function, motor side effects, and quality of life.<xref rid="b12" ref-type="bibr">12</xref>
 However, quality of life improvement should be balanced against the incidence of severe surgery-related side effects such as intracranial hemorrhage and infection, and stimulation-related side effects, such as worsening of axial signs, particularly speech.<xref rid="b12" ref-type="bibr">12</xref>
</p>
<p>The economic impact of DBS for PD has been explored in modeling studies.<xref rid="b70" ref-type="bibr">70</xref>
 Specific DBS-related expenses such as equipment, surgical theater time, and hardware as well as long-term costs such as social care are relevant.<xref rid="b71" ref-type="bibr">71</xref>
 Broad assessment tools are necessary for cost-effectiveness in view of the “acute on chronic” nature of DBS (ie, combination of initial surgical costs and long-term social care costs).<xref rid="b71" ref-type="bibr">71</xref>
 Comparative cost analyses of DBS and optimal medical therapy concluded that DBS may be more efficient clinically on the basis of UPDRS scores, and economically effective primarily through a reduction in drug requirements and delay in nursing care costs.<xref rid="b72" ref-type="bibr">72</xref>
–<xref rid="b74" ref-type="bibr">74</xref>
</p>
<p>From the evidence available, surgical management of PD alone or in combination with medical therapy offers the potential for greater improvement of motor symptoms and quality of life than medical treatment alone. DBS is now an established therapy for PD and has an endorsed safety profile. Therefore, an important issue is whether DBS should be considered earlier in the course of the disease to maintain and preserve function rather than rescue the patient. This is especially true in aspects of life such as employment, family roles, and social interaction.</p>
</sec>
<sec><title>Evidence for Earlier Use of DBS for Symptomatic Benefit in PD</title>
<p>Those in favor of commencing DBS before drug-induced motor complications become established argue that patients would benefit sooner from improved motor symptoms and quality of life. Opponents state that DBS has potentially serious risks associated with it and therefore should not be used except as a last resort. There are currently no strict criteria defining “early” DBS. Most groups consider it in terms of disease severity, treatment-related complications, and disability rather than as a time-dependent process. As research into DBS at different stages of PD evolves, it is possible that specific motor, nonmotor, and functional criteria for early DBS will emerge.</p>
<p>There is a modest volume of level 2 evidence that addresses the symptomatic benefits of early DBS (Table<xref ref-type="table" rid="tbl2">2</xref>
). A prospective randomized trial of early DBS (PD duration mean = 2.1 years) in 30 patients has been commenced and at 3 months reports that surgical complication rate and lead placement were not significantly different in the early DBS group and were in keeping with reported data.<xref rid="b75" ref-type="bibr">75</xref>
 In a randomized trial addressing the symptomatic effects of bilateral STN DBS in 10 patients with early PD (defined according to duration of disease and UPDRS III score) compared to 10 matched medically treated controls,<xref rid="b76" ref-type="bibr">76</xref>
 a significant benefit from DBS on quality of life, motor signs, reduced motor complications, and L-dopa requirement was observed.<xref rid="b68" ref-type="bibr">68</xref>
 The side effects of DBS were reported as temporary and mild. This study, although small, highlights the clinical benefits and safety profile of early use of DBS in relief of motor symptoms. In terms of disadvantages of DBS, a separate study on the same group of patients reports that patients with DBS experienced long-term psychosocial, family, and professional difficulties, elements of which were already present preoperatively.<xref rid="b77" ref-type="bibr">77</xref>
 It is known that poor preoperative affective state may predict continued depression post-DBS.<xref rid="b78" ref-type="bibr">78</xref>
</p>
<fig id="d35e515" position="float"><label>FIGURE 1</label>
<caption><p>Treatment pathways in Parkinson disease (PD) and the potential role of deep brain stimulation (DBS). The optimal treatment of PD evolves as the disease progresses. The figure shows a generally accepted paradigm for management <italic>(brown boxes)</italic>
. The current role for DBS is most commonly accepted for those PD patients with significant motor complications that limit quality of life, but whose other features (eg, L-dopa responsiveness, intact cognition) render them suitable for consideration of this therapy. We propose that DBS be considered earlier in the therapeutic program of PD <italic>(green boxes)</italic>
, when patients might be able to derive greater long-term benefit. COMT = catechol-O-methyltransferase; MAO-B = monoamine oxidase B. [Color figure can be viewed in the online issue, which is available at <ext-link ext-link-type="uri" xlink:href="http://www.annalsofneurology.org">http://www.annalsofneurology.org</ext-link>
.]</p>
</caption>
<graphic xlink:href="ana0073-0565-f1"></graphic>
</fig>
<table-wrap id="tbl2" position="float"><label>Table 2</label>
<caption><p>Studies Addressing Use of DBS Earlier in Parkinson Disease</p>
</caption>
<table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">First Author and Year</th>
<th align="center" rowspan="1" colspan="1">Summary</th>
<th align="center" rowspan="1" colspan="1">Study Type</th>
<th align="center" rowspan="1" colspan="1">Patients, No.</th>
<th align="center" rowspan="1" colspan="1">Timing of DBS and Outcome Measures</th>
<th align="center" rowspan="1" colspan="1">Follow-up, mo</th>
<th align="center" rowspan="1" colspan="1">Motor and Nonmotor Outcome</th>
</tr>
</thead>
<tbody><tr><td align="left" rowspan="1" colspan="1">Shichi 2005<xref rid="b113" ref-type="bibr">113</xref>
</td>
<td align="left" rowspan="1" colspan="1">Unilateral DBS in early stage unilateral PD</td>
<td align="left" rowspan="1" colspan="1">Prospective</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">UPDRS and Schwab England ADL score before and after DBS. DBS defined as early but actual timing unknown.</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">UPDRS without medication improved by 64%. Schwab England ADL score 23%.</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1"><hr></hr>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Schupbach 2007<xref rid="b76" ref-type="bibr">76</xref>
</td>
<td align="left" rowspan="1" colspan="1">Bilateral STN DBS vs optimal medical therapy</td>
<td align="left" rowspan="1" colspan="1">RCT</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">Early PD patients (mean 7 years duration) with mild to moderate motor signs included. Outcome measures were motor scores, quality of life, cognition, and psychiatric morbidity.</td>
<td align="left" rowspan="1" colspan="1">18</td>
<td align="left" rowspan="1" colspan="1">Significant improvement in motor signs, medication use, and quality of life in the operated group.</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1"><hr></hr>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Yamada 2009<xref rid="b79" ref-type="bibr">79</xref>
</td>
<td align="left" rowspan="1" colspan="1">UPDRS and independence of ADL assessment in bilateral STN DBS</td>
<td align="left" rowspan="1" colspan="1">Retrospective evaluation of prospective database</td>
<td align="left" rowspan="1" colspan="1">38</td>
<td align="left" rowspan="1" colspan="1">UPDRS, Schwab England ADL.</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">UPDRS scores for neuropsychiatric, axial, and ADL impairments negatively correlated with postoperative Schwab England ADL with off-medication status (<italic>p</italic>
 < 0.01).</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1"><hr></hr>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Khan 2012<xref rid="b75" ref-type="bibr">75</xref>
</td>
<td align="left" rowspan="1" colspan="1">Prospective randomized trial of STN DBS in early PD</td>
<td align="left" rowspan="1" colspan="1">RCT, randomized to DBS at mean 2.1 years PD duration</td>
<td align="left" rowspan="1" colspan="1">30</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">No results available yet except surgical morbidity data in keeping with reported values.</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1"><hr></hr>
</td>
</tr>
<tr><td align="left" rowspan="1" colspan="1">Deuschl 2013<xref rid="b80" ref-type="bibr">80</xref>
</td>
<td align="left" rowspan="1" colspan="1">Trial of STN DBS vs best medical treatment in PD patients with ≤3 years duration of motor complications (EARLYSTIM trial)</td>
<td align="left" rowspan="1" colspan="1">Prospective randomized multicenter trial</td>
<td rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">Primary outcome measure was quality of life (Parkinson's Disease Questionnaire). Secondary outcome measures were motor, psychological, and social functioning.</td>
<td align="left" rowspan="1" colspan="1">24</td>
<td align="left" rowspan="1" colspan="1">Results in press. Early DBS shows advantage over medical treatment (personal communication, G. Deuschl, 2012).</td>
</tr>
</tbody>
</table>
<table-wrap-foot><fn><p>ADL = activities of daily living; DBS = deep brain stimulation; PD = Parkinson disease; RCT = randomized clinical trial; STN = subthalamic nucleus; UPDRS = Unified Parkinson Disease Rating Scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>There are a number of small anecdotal reports of DBS in early PD. For instance, a class 4 evaluation of bilateral STN stimulation performed in the earlier and later stages of PD, defined by disease duration and function, found that earlier DBS resulted in significantly greater postoperative independence as assessed by ADL.<xref rid="b79" ref-type="bibr">79</xref>
 The multicenter EARLYSTIM trial comparing early DBS a mean of 7.5 years after diagnosis with best medical therapy<xref rid="b80" ref-type="bibr">80</xref>
 has recently been published.<xref rid="b81" ref-type="bibr">81</xref>
 STN was performed in 120 PD patients and compared to 127 patients in the medical therapy group. Mean age was 52 years, L-dopa therapy duration was 4.9 years, and fluctuations and/or dyskinesias had been present for 1.5 or 1.7 years, respectively. The primary endpoint was quality of life at 24 months as determined by the Parkinson's Disease Questionnaire (PDQ)−39, and showed an 8-point difference in favor of the STN group. PDQ-39 benefit in the STN group was evident at 5 months, with a 10-point improvement over medical therapy. There were additional benefits for the STN group in relation to motor function, ADL, and L-dopa–related motor complications. Serious adverse events occurred in 54.8% of the STN group (17.7% device-related) and 44.1% of the medical group. Those related to surgery or the device resolved completely with the exception of 1 that left a cutaneous scar. There were 2 suicides in the STN group and 1 in the medical therapy group, but overall there was no difference between the groups in suicidal behavior.</p>
<p>Evidence for the economic benefit of early DBS comes from a recent Markov state transition decision analytic model of STN DBS applied at an early versus delayed stage, defined by off time.<xref rid="b82" ref-type="bibr">82</xref>
 This analysis concluded that early DBS increases quality-adjusted life years and reduces treatment costs; the need for further clinical trials in this area was supported. There may be scope to identify specific subgroups that are likely to have long-term symptomatic benefit from early DBS and for these patients to be referred to a specialist center for evaluation. From the evidence available, such groups may include young patients, those with rapidly progressive disease, those with treatment-related complications, those who have been confirmed to have sustained L-dopa–responsive pathology with other forms of PD excluded, medication-intolerant patients, those with unilateral disease, and active elderly patients.<xref rid="b82" ref-type="bibr">82</xref>
,<xref rid="b83" ref-type="bibr">83</xref>
</p>
<p>One of the longest follow-up studies of DBS in PD showed that at 10 years the effect of DBS was maintained in all motor domains except axial symptoms, which negated some of the overall motor benefit.<xref rid="b39" ref-type="bibr">39</xref>
 Benefits in the domain of ADL may not be maintained beyond 9 years of follow-up.<xref rid="b38" ref-type="bibr">38</xref>
 There is some evidence of late cognitive decline in patients with DBS, but this may simply reflect disease progression.<xref rid="b14" ref-type="bibr">14</xref>
,<xref rid="b38" ref-type="bibr">38</xref>
 However, there have been no comparisons to best medical therapy with respect to the changes in ADL function expected over this period of time.</p>
</sec>
<sec><title>Evidence for Earlier Use of DBS for Disease Modification in PD</title>
<p>Slowing the progression of PD is a major goal of therapy, but presents obvious significant challenges, mainly related to the complex etiology of the disease.<xref rid="b84" ref-type="bibr">84</xref>
–<xref rid="b86" ref-type="bibr">86</xref>
 There has been some evidence suggesting that STN DBS may have a disease-modifying role in animal models of PD, but a major limitation of these results is lack of reproducibility in humans. This may in turn be due to the limitations of the 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) models of PD in reflecting the pathophysiological mechanisms, the differing time course of disease development, and the effects of medication in humans.</p>
<p>In a 6-OHDA rodent model of PD with up to 75% of nigral neurons lost and up to 93% reduction in dopamine levels, STN DBS prevented further neuronal loss.<xref rid="b87" ref-type="bibr">87</xref>
 This study also demonstrated that despite apparent neuroprotection, striatal dopamine levels were not increased. The authors highlight the role of this study in suggesting that DBS may have benefit in early PD when fewer neurons have been lost. There is no research yet into the critical mass of neurons at which DBS might be most effective and below which it could have limited scope to work. The neuroprotective effect of STN DBS in the rat model has also been demonstrated by other groups<xref rid="b88" ref-type="bibr">88</xref>
,<xref rid="b89" ref-type="bibr">89</xref>
; STN lesioning in the 6-OHDA rat model of PD resulted in ⅓ of nigral neurons being preserved.<xref rid="b90" ref-type="bibr">90</xref>
</p>
<p>In the hemiparkinsonian MPTP primate model, STN DBS significantly increases striatal dopamine levels, attenuates loss of dopaminergic cells in the periaqueductal gray matter of primates, and leads to a mean of 20% more nigral neurons with symptomatic improvement.<xref rid="b91" ref-type="bibr">91</xref>
–<xref rid="b93" ref-type="bibr">93</xref>
 The mechanisms by which DBS could mediate neuroprotection are unknown, but have been proposed to include a reduction in excitotoxically induced damage.<xref rid="b92" ref-type="bibr">92</xref>
</p>
<p>Because advanced PD is associated with probably >85% nigral cell death and early PD with approximately 50% cell death,<xref rid="b94" ref-type="bibr">94</xref>
 it is probable that significant changes to neural networks have already been established even before the patient presents clinically.<xref rid="b95" ref-type="bibr">95</xref>
–<xref rid="b100" ref-type="bibr">100</xref>
 It is possible that DBS applied to mild rather than advanced PD will have a head start, because there are more neurons available at baseline to act upon. There is a parallel hypothesis to this in terms of early initiation of medical therapy in PD and its potential for beneficial plastic changes in basal ganglia circuitry.<xref rid="b101" ref-type="bibr">101</xref>
</p>
<p>There are few human studies examining whether DBS has any disease-modifying effects in PD. An 18F-fluorodeoxyglucose (FDG) PET study in 17 patients showed no slowing of the progression of PD, suggesting that DBS may not afford any neuroprotection.<xref rid="b102" ref-type="bibr">102</xref>
,<xref rid="b103" ref-type="bibr">103</xref>
 More optimistic results come from another study using [11C] raclopride PET, which found that STN DBS raised striatal dopamine levels and further increased levels after L-dopa administration in patients experiencing the wearing off phenomenon.<xref rid="b104" ref-type="bibr">104</xref>
 This study may have been limited because duration of DBS withdrawal before clinical evaluation was only 30 to 40 minutes. However, PD signs may become progressively worse over a span of hours after switching off the stimulation,<xref rid="b105" ref-type="bibr">105</xref>
 and sudden failure of the DBS battery in PD patients has been reported as an emergency condition, due to severe relapse of symptoms.<xref rid="b106" ref-type="bibr">106</xref>
</p>
<p>If any neuroprotective properties of DBS are limited to dopaminergic neurons, L-dopa–resistant motor and nonmotor symptoms are unlikely to be DBS-responsive.<xref rid="b107" ref-type="bibr">107</xref>
 However, there is recent evidence on FDG PET in advanced PD that DBS-induced effects of metabolism extend to include cerebellar and limbic nuclei and frontal lobes.<xref rid="b108" ref-type="bibr">108</xref>
,<xref rid="b109" ref-type="bibr">109</xref>
 This suggests that DBS may modulate nondopaminergic networks, which may in the long term impact nonmotor clinical features of PD.</p>
<p>Nevertheless, the most recent long-term follow-up studies with 5 to 10 years of continuous STN DBS have failed to indicate a nondopaminergic neuroprotective benefit from DBS. Patients who had STN DBS in situ for 8 to 10 years had maintenance of motor benefits and functional improvement despite reduction in L-dopa dose, but had significant decline in postural stability, axial symptoms, and a nonsignificant decline in cognition.<xref rid="b39" ref-type="bibr">39</xref>
 The conclusions from long-term follow-up studies suggest that the greatest sources of disability in late-stage PD, including drug-resistant axial motor features, psychiatric disorders, dysautonomia, and cognitive decline, are probably not significantly modified by DBS.<xref rid="b110" ref-type="bibr">110</xref>
 An editorial discussing a 9-year follow-up of DBS in PD highlights that its role may shift if there is success in the development of disease-modifying medical therapies that treat dopamine deficiency but do not induce the disabling motor complications that currently are the strongest indication for DBS.<xref rid="b111" ref-type="bibr">111</xref>
</p>
</sec>
<sec><title>Future Directions</title>
<p>Evidence is emerging that DBS may be suitable for use in less advanced PD, at an earlier stage of disease than it is currently commonly applied. This proposal is supported by the results of the EARLYSTIM trial. DBS should be considered and discussed with the patient when the burden of the disease begins to have an impact on the quality of life and medical therapy fails to provide adequate control or causes significant side effects. The improving short- and long-term safety profile of DBS makes earlier application a realistic possibility; centers that might consider this approach must conduct regular prospective evaluations of their outcomes, including both clinical benefit and adverse effects.</p>
</sec>
<sec sec-type="conclusions"><title>Conclusion</title>
<p>The treatment of PD has evolved significantly since the introduction of L-dopa 40 years ago. Advances in our understanding of the natural history of the disease and the therapies available for its management require us periodically to reappraise our strategies for patients.<xref rid="b91" ref-type="bibr">91</xref>
 Advances in surgical techniques, brain imaging, and device design have brought us to the position where we should re-evaluate which patients we can consider for DBS and at what point in their disease this is offered. We may be entering a period when DBS is considered earlier in the disease course than has hitherto been the case.</p>
</sec>
</body>
<back><sec><title>Potential Conflicts of Interest</title>
<p>E.M.: consultancy, Medtronic; grants/grants pending, St. Jude, CIHR, CurePSP; speaking fees, Medtronic. A.E.L.: consultancy, Biovail, Ceregene, Novartis, Merck Serono, Solvay, Tea, Abbott, Allon Therapeutics, AstraZeneca, Eisai, GSK, MSD, BMS, Medtronic; expert testimony, welding rod; grants/grants pending, Ontario Problem Gambling Research Centre, Canadian Institutes of Health Research, Michael J. Fox Foundation, National Parkinson Foundation; royalties, Saunders, Wiley-Blackwell, Johns Hopkins Press, Cambridge University Press. A.H.V.S.: royalties, Elsevier, Wiley-Blackwell, OUP; paid educational presentations, BI, GSK, Teva-Lundbeck, Orion-Novartis, Merck, UCB.</p>
</sec>
<ref-list><title>References</title>
<ref id="b1"><label>1</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twelves</surname>
<given-names>D</given-names>
</name>
<name><surname>Perkins</surname>
<given-names>KS</given-names>
</name>
<name><surname>Counsell</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Systematic review of incidence studies of Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2003</year>
<volume>18</volume>
<fpage>19</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">12518297</pub-id>
</element-citation>
</ref>
<ref id="b2"><label>2</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wickremaratchi</surname>
<given-names>MM</given-names>
</name>
<name><surname>Ben-Shlomo</surname>
<given-names>Y</given-names>
</name>
<name><surname>Morris</surname>
<given-names>HR</given-names>
</name>
</person-group>
<article-title>The effect of onset age on the clinical features of Parkinson's disease</article-title>
<source>Eur J Neurol</source>
<year>2009</year>
<volume>16</volume>
<fpage>450</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="pmid">19187262</pub-id>
</element-citation>
</ref>
<ref id="b3"><label>3</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname>
<given-names>ER</given-names>
</name>
<name><surname>Constantinescu</surname>
<given-names>R</given-names>
</name>
<name><surname>Thompson</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030</article-title>
<source>Neurology</source>
<year>2007</year>
<volume>68</volume>
<fpage>384</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="pmid">17082464</pub-id>
</element-citation>
</ref>
<ref id="b4"><label>4</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Findley</surname>
<given-names>LJ</given-names>
</name>
</person-group>
<article-title>The economic impact of Parkinson's disease</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2007</year>
<volume>13</volume>
<issue>suppl</issue>
<fpage>S8</fpage>
<lpage>S12</lpage>
<pub-id pub-id-type="pmid">17702630</pub-id>
</element-citation>
</ref>
<ref id="b5"><label>5</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vossius</surname>
<given-names>C</given-names>
</name>
<name><surname>Nilsen</surname>
<given-names>OB</given-names>
</name>
<name><surname>Larsen</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Parkinson's disease and nursing home placement: the economic impact of the need for care</article-title>
<source>Eur J Neurol</source>
<year>2009</year>
<volume>16</volume>
<fpage>194</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="pmid">19146640</pub-id>
</element-citation>
</ref>
<ref id="b6"><label>6</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname>
<given-names>Y</given-names>
</name>
<name><surname>Balzer-Geldsetzer</surname>
<given-names>M</given-names>
</name>
<name><surname>Spottke</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Longitudinal study of the socioeconomic burden of Parkinson's disease in Germany</article-title>
<source>Eur J Neurol</source>
<year>2010</year>
<volume>17</volume>
<fpage>1156</fpage>
<lpage>1163</lpage>
<pub-id pub-id-type="pmid">20345926</pub-id>
</element-citation>
</ref>
<ref id="b7"><label>7</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weintraub</surname>
<given-names>D</given-names>
</name>
<name><surname>Comella</surname>
<given-names>CL</given-names>
</name>
<name><surname>Horn</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Parkinson's disease—Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment</article-title>
<source>Am J Manag Care</source>
<year>2008</year>
<volume>14</volume>
<fpage>S40</fpage>
<lpage>S48</lpage>
<pub-id pub-id-type="pmid">18402507</pub-id>
</element-citation>
</ref>
<ref id="b8"><label>8</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>Parkinson's disease: health-related quality of life, economic cost, and implications of early treatment</article-title>
<source>Am J Manag Care</source>
<year>2010</year>
<volume>16</volume>
<issue>suppl Implications</issue>
<fpage>S87</fpage>
<lpage>S93</lpage>
<pub-id pub-id-type="pmid">20297871</pub-id>
</element-citation>
</ref>
<ref id="b9"><label>9</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaudhuri</surname>
<given-names>KR</given-names>
</name>
<name><surname>Healy</surname>
<given-names>DG</given-names>
</name>
<name><surname>Schapira</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Non-motor symptoms of Parkinson's disease: diagnosis and management</article-title>
<source>Lancet Neurol</source>
<year>2006</year>
<volume>5</volume>
<fpage>235</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="pmid">16488379</pub-id>
</element-citation>
</ref>
<ref id="b10"><label>10</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deuschl</surname>
<given-names>G</given-names>
</name>
<name><surname>Schade-Brittinger</surname>
<given-names>C</given-names>
</name>
<name><surname>Krack</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized trial of deep-brain stimulation for Parkinson's disease</article-title>
<source>N Engl J Med</source>
<year>2006</year>
<volume>355</volume>
<fpage>896</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="pmid">16943402</pub-id>
</element-citation>
</ref>
<ref id="b11"><label>11</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname>
<given-names>MS</given-names>
</name>
<name><surname>Fernandez</surname>
<given-names>HH</given-names>
</name>
<name><surname>Wu</surname>
<given-names>SS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial</article-title>
<source>Ann Neurol</source>
<year>2009</year>
<volume>65</volume>
<fpage>586</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="pmid">19288469</pub-id>
</element-citation>
</ref>
<ref id="b12"><label>12</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname>
<given-names>FM</given-names>
</name>
<name><surname>Follett</surname>
<given-names>K</given-names>
</name>
<name><surname>Stern</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial</article-title>
<source>JAMA</source>
<year>2009</year>
<volume>301</volume>
<fpage>63</fpage>
<lpage>73</lpage>
<pub-id pub-id-type="pmid">19126811</pub-id>
</element-citation>
</ref>
<ref id="b13"><label>13</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Follett</surname>
<given-names>KA</given-names>
</name>
<name><surname>Weaver</surname>
<given-names>FM</given-names>
</name>
<name><surname>Stern</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease</article-title>
<source>N Engl J Med</source>
<year>2010</year>
<volume>362</volume>
<fpage>2077</fpage>
<lpage>2091</lpage>
<pub-id pub-id-type="pmid">20519680</pub-id>
</element-citation>
</ref>
<ref id="b14"><label>14</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleiner-Fisman</surname>
<given-names>G</given-names>
</name>
<name><surname>Herzog</surname>
<given-names>J</given-names>
</name>
<name><surname>Fisman</surname>
<given-names>DN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes</article-title>
<source>Mov Disord</source>
<year>2006</year>
<volume>21</volume>
<issue>suppl 14</issue>
<fpage>S290</fpage>
<lpage>S304</lpage>
<pub-id pub-id-type="pmid">16892449</pub-id>
</element-citation>
</ref>
<ref id="b15"><label>15</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkmann</surname>
<given-names>J</given-names>
</name>
<name><surname>Allert</surname>
<given-names>N</given-names>
</name>
<name><surname>Voges</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term results of bilateral pallidal stimulation in Parkinson's disease</article-title>
<source>Ann Neurol</source>
<year>2004</year>
<volume>55</volume>
<fpage>871</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="pmid">15174022</pub-id>
</element-citation>
</ref>
<ref id="b16"><label>16</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houeto</surname>
<given-names>JL</given-names>
</name>
<name><surname>Damier</surname>
<given-names>P</given-names>
</name>
<name><surname>Bejjani</surname>
<given-names>PB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic stimulation in Parkinson disease: a multidisciplinary approach</article-title>
<source>Arch Neurol</source>
<year>2000</year>
<volume>57</volume>
<fpage>461</fpage>
<lpage>465</lpage>
<pub-id pub-id-type="pmid">10768618</pub-id>
</element-citation>
</ref>
<ref id="b17"><label>17</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname>
<given-names>FM</given-names>
</name>
<name><surname>Follett</surname>
<given-names>KA</given-names>
</name>
<name><surname>Stern</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes</article-title>
<source>Neurology</source>
<year>2012</year>
<volume>79</volume>
<fpage>55</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="pmid">22722632</pub-id>
</element-citation>
</ref>
<ref id="b18"><label>18</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evidente</surname>
<given-names>VG</given-names>
</name>
<name><surname>Premkumar</surname>
<given-names>AP</given-names>
</name>
<name><surname>Adler</surname>
<given-names>CH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease</article-title>
<source>Acta Neurol Scand</source>
<year>2011</year>
<volume>124</volume>
<fpage>211</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="pmid">20969559</pub-id>
</element-citation>
</ref>
<ref id="b19"><label>19</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname>
<given-names>E</given-names>
</name>
<name><surname>Lozano</surname>
<given-names>AM</given-names>
</name>
<name><surname>Pollak</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2010</year>
<volume>25</volume>
<fpage>578</fpage>
<lpage>586</lpage>
<pub-id pub-id-type="pmid">20213817</pub-id>
</element-citation>
</ref>
<ref id="b20"><label>20</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name><surname>Widner</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Deep brain stimulation for Parkinson's disease: patient selection and evaluation</article-title>
<source>Mov Disord</source>
<year>2002</year>
<volume>17</volume>
<issue>suppl 3</issue>
<fpage>S94</fpage>
<lpage>S101</lpage>
<pub-id pub-id-type="pmid">11948762</pub-id>
</element-citation>
</ref>
<ref id="b21"><label>21</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgante</surname>
<given-names>L</given-names>
</name>
<name><surname>Morgante</surname>
<given-names>F</given-names>
</name>
<name><surname>Moro</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2007</year>
<volume>13</volume>
<fpage>528</fpage>
<lpage>531</lpage>
<pub-id pub-id-type="pmid">17347021</pub-id>
</element-citation>
</ref>
<ref id="b22"><label>22</label>
<element-citation publication-type="other"><collab>NICE</collab>
<article-title>Deep brain stimulation for Parkinson's disease</article-title>
<comment>Available at: <ext-link ext-link-type="uri" xlink:href="http:/www.nice.org.uk/IPG019">http:/www.nice.org.uk/IPG019</ext-link>
</comment>
</element-citation>
</ref>
<ref id="b23"><label>23</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname>
<given-names>AE</given-names>
</name>
<name><surname>Houeto</surname>
<given-names>JL</given-names>
</name>
<name><surname>Krack</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep brain stimulation: preoperative issues</article-title>
<source>Mov Disord</source>
<year>2006</year>
<volume>21</volume>
<issue>suppl 14</issue>
<fpage>S171</fpage>
<lpage>S196</lpage>
<pub-id pub-id-type="pmid">16810718</pub-id>
</element-citation>
</ref>
<ref id="b24"><label>24</label>
<element-citation publication-type="other"><collab>NICE</collab>
<article-title>Parkinson's disease</article-title>
<comment>Available at: <ext-link ext-link-type="uri" xlink:href="http:/www.nice.org.uk/CG035">http:/www.nice.org.uk/CG035</ext-link>
</comment>
</element-citation>
</ref>
<ref id="b25"><label>25</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname>
<given-names>SH</given-names>
</name>
<name><surname>Katzenschlager</surname>
<given-names>R</given-names>
</name>
<name><surname>Lim</surname>
<given-names>SY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2011</year>
<volume>26</volume>
<issue>suppl 3</issue>
<fpage>S2</fpage>
<lpage>S41</lpage>
<pub-id pub-id-type="pmid">22021173</pub-id>
</element-citation>
</ref>
<ref id="b26"><label>26</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koller</surname>
<given-names>WC</given-names>
</name>
<name><surname>Tse</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Unmet medical needs in Parkinson's disease</article-title>
<source>Neurology</source>
<year>2004</year>
<volume>62</volume>
<fpage>S1</fpage>
<lpage>S8</lpage>
<pub-id pub-id-type="pmid">14718675</pub-id>
</element-citation>
</ref>
<ref id="b27"><label>27</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poewe</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Treatments for Parkinson disease—past achievements and current clinical needs</article-title>
<source>Neurology</source>
<year>2009</year>
<volume>72</volume>
<fpage>S65</fpage>
<lpage>S73</lpage>
<pub-id pub-id-type="pmid">19221317</pub-id>
</element-citation>
</ref>
<ref id="b28"><label>28</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hatano</surname>
<given-names>T</given-names>
</name>
<name><surname>Kubo</surname>
<given-names>SI</given-names>
</name>
<name><surname>Shimo</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unmet needs of patients with Parkinson's disease: interview survey of patients and caregivers</article-title>
<source>J Int Med Res</source>
<year>2009</year>
<volume>37</volume>
<fpage>717</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="pmid">19589255</pub-id>
</element-citation>
</ref>
<ref id="b29"><label>29</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Disease modification in Parkinson's disease</article-title>
<source>Lancet Neurol</source>
<year>2004</year>
<volume>3</volume>
<fpage>362</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="pmid">15157851</pub-id>
</element-citation>
</ref>
<ref id="b30"><label>30</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname>
<given-names>E</given-names>
</name>
<name><surname>Lang</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Criteria for deep-brain stimulation in Parkinson's disease: review and analysis</article-title>
<source>Expert Rev Neurother</source>
<year>2006</year>
<volume>6</volume>
<fpage>1695</fpage>
<lpage>1705</lpage>
<pub-id pub-id-type="pmid">17144783</pub-id>
</element-citation>
</ref>
<ref id="b31"><label>31</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronstein</surname>
<given-names>JM</given-names>
</name>
<name><surname>Tagliati</surname>
<given-names>M</given-names>
</name>
<name><surname>Alterman</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues</article-title>
<source>Arch Neurol</source>
<year>2011</year>
<volume>68</volume>
<fpage>165</fpage>
<pub-id pub-id-type="pmid">20937936</pub-id>
</element-citation>
</ref>
<ref id="b32"><label>32</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moro</surname>
<given-names>E</given-names>
</name>
<name><surname>Allert</surname>
<given-names>N</given-names>
</name>
<name><surname>Eleopra</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease</article-title>
<source>J Neurol</source>
<year>2009</year>
<volume>256</volume>
<fpage>83</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">19221846</pub-id>
</element-citation>
</ref>
<ref id="b33"><label>33</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachter</surname>
<given-names>T</given-names>
</name>
<name><surname>Minguez-Castellanos</surname>
<given-names>A</given-names>
</name>
<name><surname>Valldeoriola</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A tool to improve pre-selection for deep brain stimulation in patients with Parkinson's disease</article-title>
<source>J Neurol</source>
<year>2011</year>
<volume>258</volume>
<fpage>641</fpage>
<lpage>646</lpage>
<pub-id pub-id-type="pmid">21088849</pub-id>
</element-citation>
</ref>
<ref id="b34"><label>34</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krack</surname>
<given-names>P</given-names>
</name>
<name><surname>Batir</surname>
<given-names>A</given-names>
</name>
<name><surname>Van</surname>
<given-names>BN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease</article-title>
<source>N Engl J Med</source>
<year>2003</year>
<volume>349</volume>
<fpage>1925</fpage>
<lpage>1934</lpage>
<pub-id pub-id-type="pmid">14614167</pub-id>
</element-citation>
</ref>
<ref id="b35"><label>35</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname>
<given-names>A</given-names>
</name>
<name><surname>Romito</surname>
<given-names>LM</given-names>
</name>
<name><surname>Daniele</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants</article-title>
<source>Brain</source>
<year>2010</year>
<volume>133</volume>
<fpage>2664</fpage>
<lpage>2676</lpage>
<pub-id pub-id-type="pmid">20802207</pub-id>
</element-citation>
</ref>
<ref id="b36"><label>36</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitek</surname>
<given-names>JL</given-names>
</name>
<name><surname>Lyons</surname>
<given-names>KE</given-names>
</name>
<name><surname>Bakay</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS-PD)</article-title>
<source>Mov Disord</source>
<year>2010</year>
<volume>25</volume>
<fpage>1530</fpage>
<lpage>1537</lpage>
<pub-id pub-id-type="pmid">20544809</pub-id>
</element-citation>
</ref>
<ref id="b37"><label>37</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wider</surname>
<given-names>C</given-names>
</name>
<name><surname>Russmann</surname>
<given-names>H</given-names>
</name>
<name><surname>Villemure</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation</article-title>
<source>Arch Neurol</source>
<year>2006</year>
<volume>63</volume>
<fpage>951</fpage>
<lpage>955</lpage>
<pub-id pub-id-type="pmid">16831963</pub-id>
</element-citation>
</ref>
<ref id="b38"><label>38</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zibetti</surname>
<given-names>M</given-names>
</name>
<name><surname>Merola</surname>
<given-names>A</given-names>
</name>
<name><surname>Rizzi</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2011</year>
<volume>26</volume>
<fpage>2327</fpage>
<lpage>2334</lpage>
<pub-id pub-id-type="pmid">22012750</pub-id>
</element-citation>
</ref>
<ref id="b39"><label>39</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castrioto</surname>
<given-names>A</given-names>
</name>
<name><surname>Lozano</surname>
<given-names>AM</given-names>
</name>
<name><surname>Poon</surname>
<given-names>YY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation</article-title>
<source>Arch Neurol</source>
<year>2011</year>
<volume>68</volume>
<fpage>1550</fpage>
<lpage>1556</lpage>
<pub-id pub-id-type="pmid">21825213</pub-id>
</element-citation>
</ref>
<ref id="b40"><label>40</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Follett</surname>
<given-names>KA</given-names>
</name>
<name><surname>Torres-Russotto</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Deep brain stimulation of globus pallidus interna, subthalamic nucleus, and pedunculopontine nucleus for Parkinson's disease: which target?</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2012</year>
<volume>18</volume>
<issue>suppl 1</issue>
<fpage>S165</fpage>
<lpage>S167</lpage>
<pub-id pub-id-type="pmid">22166422</pub-id>
</element-citation>
</ref>
<ref id="b41"><label>41</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariz</surname>
<given-names>MI</given-names>
</name>
<name><surname>Krack</surname>
<given-names>P</given-names>
</name>
<name><surname>Alesch</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>2008</year>
<volume>79</volume>
<fpage>694</fpage>
<lpage>699</lpage>
<pub-id pub-id-type="pmid">17898034</pub-id>
</element-citation>
</ref>
<ref id="b42"><label>42</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fimm</surname>
<given-names>B</given-names>
</name>
<name><surname>Heber</surname>
<given-names>IA</given-names>
</name>
<name><surname>Coenen</surname>
<given-names>VA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2009</year>
<volume>24</volume>
<fpage>1613</fpage>
<lpage>1620</lpage>
<pub-id pub-id-type="pmid">19533754</pub-id>
</element-citation>
</ref>
<ref id="b43"><label>43</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname>
<given-names>CH</given-names>
</name>
<name><surname>Rick</surname>
<given-names>JH</given-names>
</name>
<name><surname>Danish</surname>
<given-names>SF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease</article-title>
<source>Int J Geriatr Psychiatry</source>
<year>2009</year>
<volume>24</volume>
<fpage>443</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="pmid">19016252</pub-id>
</element-citation>
</ref>
<ref id="b44"><label>44</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro</surname>
<given-names>JM</given-names>
</name>
<name><surname>Pahwa</surname>
<given-names>R</given-names>
</name>
<name><surname>Lyons</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>The impact of bilateral subthalamic stimulation on non-motor symptoms of Parkinson's disease</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2011</year>
<volume>17</volume>
<fpage>606</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="pmid">21669545</pub-id>
</element-citation>
</ref>
<ref id="b45"><label>45</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strutt</surname>
<given-names>AM</given-names>
</name>
<name><surname>Simpson</surname>
<given-names>R</given-names>
</name>
<name><surname>Jankovic</surname>
<given-names>J</given-names>
</name>
<name><surname>York</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease</article-title>
<source>Eur J Neurol</source>
<year>2012</year>
<volume>19</volume>
<fpage>121</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="pmid">21668586</pub-id>
</element-citation>
</ref>
<ref id="b46"><label>46</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname>
<given-names>A</given-names>
</name>
<name><surname>Baumgartner</surname>
<given-names>L</given-names>
</name>
<name><surname>Binder</surname>
<given-names>DK</given-names>
</name>
</person-group>
<article-title>Effect of deep brain stimulation on autonomic dysfunction in patients with Parkinson's disease</article-title>
<source>J Clin Neurosci</source>
<year>2011</year>
<volume>18</volume>
<fpage>804</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="pmid">21489800</pub-id>
</element-citation>
</ref>
<ref id="b47"><label>47</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witjas</surname>
<given-names>T</given-names>
</name>
<name><surname>Kaphan</surname>
<given-names>E</given-names>
</name>
<name><surname>Regis</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2007</year>
<volume>22</volume>
<fpage>1729</fpage>
<lpage>1734</lpage>
<pub-id pub-id-type="pmid">17557355</pub-id>
</element-citation>
</ref>
<ref id="b48"><label>48</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St George</surname>
<given-names>RJ</given-names>
</name>
<name><surname>Carlson-Kuhta</surname>
<given-names>P</given-names>
</name>
<name><surname>Burchiel</surname>
<given-names>KJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease</article-title>
<source>J Neurosurg</source>
<year>2012</year>
<volume>116</volume>
<fpage>1347</fpage>
<lpage>1356</lpage>
<pub-id pub-id-type="pmid">22424564</pub-id>
</element-citation>
</ref>
<ref id="b49"><label>49</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothlind</surname>
<given-names>JC</given-names>
</name>
<name><surname>Cockshott</surname>
<given-names>RW</given-names>
</name>
<name><surname>Starr</surname>
<given-names>PA</given-names>
</name>
<name><surname>Marks</surname>
<given-names>WJ</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease</article-title>
<source>J Int Neuropsychol Soc</source>
<year>2007</year>
<volume>13</volume>
<fpage>68</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">17166305</pub-id>
</element-citation>
</ref>
<ref id="b50"><label>50</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahodne</surname>
<given-names>LB</given-names>
</name>
<name><surname>Okun</surname>
<given-names>MS</given-names>
</name>
<name><surname>Foote</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus</article-title>
<source>J Neurol</source>
<year>2009</year>
<volume>256</volume>
<fpage>1321</fpage>
<lpage>1329</lpage>
<pub-id pub-id-type="pmid">19363633</pub-id>
</element-citation>
</ref>
<ref id="b51"><label>51</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname>
<given-names>DT</given-names>
</name>
<name><surname>Zhu</surname>
<given-names>XL</given-names>
</name>
<name><surname>Yeung</surname>
<given-names>JH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complications of deep brain stimulation: a collective review</article-title>
<source>Asian J Surg</source>
<year>2009</year>
<volume>32</volume>
<fpage>258</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="pmid">19892631</pub-id>
</element-citation>
</ref>
<ref id="b52"><label>52</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voon</surname>
<given-names>V</given-names>
</name>
<name><surname>Krack</surname>
<given-names>P</given-names>
</name>
<name><surname>Lang</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease</article-title>
<source>Brain</source>
<year>2008</year>
<volume>131</volume>
<fpage>2720</fpage>
<lpage>2728</lpage>
<pub-id pub-id-type="pmid">18941146</pub-id>
</element-citation>
</ref>
<ref id="b53"><label>53</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsch-Darrow</surname>
<given-names>L</given-names>
</name>
<name><surname>Zahodne</surname>
<given-names>LB</given-names>
</name>
<name><surname>Marsiske</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2011</year>
<volume>17</volume>
<fpage>182</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="pmid">21256069</pub-id>
</element-citation>
</ref>
<ref id="b54"><label>54</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porat</surname>
<given-names>O</given-names>
</name>
<name><surname>Cohen</surname>
<given-names>OS</given-names>
</name>
<name><surname>Schwartz</surname>
<given-names>R</given-names>
</name>
<name><surname>Hassin-Baer</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease</article-title>
<source>J Neuropsychiatry Clin Neurosci</source>
<year>2009</year>
<volume>21</volume>
<fpage>398</fpage>
<lpage>405</lpage>
<pub-id pub-id-type="pmid">19996248</pub-id>
</element-citation>
</ref>
<ref id="b55"><label>55</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witt</surname>
<given-names>K</given-names>
</name>
<name><surname>Daniels</surname>
<given-names>C</given-names>
</name>
<name><surname>Reiff</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study</article-title>
<source>Lancet Neurol</source>
<year>2008</year>
<volume>7</volume>
<fpage>605</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="pmid">18538636</pub-id>
</element-citation>
</ref>
<ref id="b56"><label>56</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peron</surname>
<given-names>J</given-names>
</name>
<name><surname>Biseul</surname>
<given-names>I</given-names>
</name>
<name><surname>Leray</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic nucleus stimulation affects fear and sadness recognition in Parkinson's disease</article-title>
<source>Neuropsychology</source>
<year>2010</year>
<volume>24</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">20063943</pub-id>
</element-citation>
</ref>
<ref id="b57"><label>57</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demetriades</surname>
<given-names>P</given-names>
</name>
<name><surname>Rickards</surname>
<given-names>H</given-names>
</name>
<name><surname>Cavanna</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects</article-title>
<source>Parkinsons Dis</source>
<year>2011</year>
<volume>2011</volume>
<fpage>658415</fpage>
<pub-id pub-id-type="pmid">21403902</pub-id>
</element-citation>
</ref>
<ref id="b58"><label>58</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broen</surname>
<given-names>M</given-names>
</name>
<name><surname>Duits</surname>
<given-names>A</given-names>
</name>
<name><surname>Visser-Vandewalle</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2011</year>
<volume>17</volume>
<fpage>413</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">21382739</pub-id>
</element-citation>
</ref>
<ref id="b59"><label>59</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appleby</surname>
<given-names>BS</given-names>
</name>
<name><surname>Duggan</surname>
<given-names>PS</given-names>
</name>
<name><surname>Regenberg</surname>
<given-names>A</given-names>
</name>
<name><surname>Rabins</surname>
<given-names>PV</given-names>
</name>
</person-group>
<article-title>Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years' experience</article-title>
<source>Mov Disord</source>
<year>2007</year>
<volume>22</volume>
<fpage>1722</fpage>
<lpage>1728</lpage>
<pub-id pub-id-type="pmid">17721929</pub-id>
</element-citation>
</ref>
<ref id="b60"><label>60</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heo</surname>
<given-names>JH</given-names>
</name>
<name><surname>Lee</surname>
<given-names>KM</given-names>
</name>
<name><surname>Paek</surname>
<given-names>SH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease</article-title>
<source>J Neurol Sci</source>
<year>2008</year>
<volume>273</volume>
<fpage>19</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">18640690</pub-id>
</element-citation>
</ref>
<ref id="b61"><label>61</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberts</surname>
<given-names>JL</given-names>
</name>
<name><surname>Voelcker-Rehage</surname>
<given-names>C</given-names>
</name>
<name><surname>Hallahan</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients</article-title>
<source>Brain</source>
<year>2008</year>
<volume>131</volume>
<fpage>3348</fpage>
<lpage>3360</lpage>
<pub-id pub-id-type="pmid">18842609</pub-id>
</element-citation>
</ref>
<ref id="b62"><label>62</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thobois</surname>
<given-names>S</given-names>
</name>
<name><surname>Ardouin</surname>
<given-names>C</given-names>
</name>
<name><surname>Lhommée</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation</article-title>
<source>Brain</source>
<year>2010</year>
<volume>133</volume>
<fpage>1111</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="pmid">20237128</pub-id>
</element-citation>
</ref>
<ref id="b63"><label>63</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Videnovic</surname>
<given-names>A</given-names>
</name>
<name><surname>Metman</surname>
<given-names>LV</given-names>
</name>
</person-group>
<article-title>Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting</article-title>
<source>Mov Disord</source>
<year>2008</year>
<volume>23</volume>
<fpage>343</fpage>
<lpage>349</lpage>
<pub-id pub-id-type="pmid">17987644</pub-id>
</element-citation>
</ref>
<ref id="b64"><label>64</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amara</surname>
<given-names>AW</given-names>
</name>
<name><surname>Watts</surname>
<given-names>RL</given-names>
</name>
<name><surname>Walker</surname>
<given-names>HC</given-names>
</name>
</person-group>
<article-title>The effects of deep brain stimulation on sleep in Parkinson's disease</article-title>
<source>Ther Adv Neurol Disord</source>
<year>2011</year>
<volume>4</volume>
<fpage>15</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">21339905</pub-id>
</element-citation>
</ref>
<ref id="b65"><label>65</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname>
<given-names>DC</given-names>
</name>
<name><surname>Lam</surname>
<given-names>S</given-names>
</name>
<name><surname>Gorgulho</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Eyelid apraxia associated with subthalamic nucleus deep brain stimulation</article-title>
<source>Neurology</source>
<year>2006</year>
<volume>66</volume>
<fpage>1451</fpage>
<lpage>1452</lpage>
<pub-id pub-id-type="pmid">16682687</pub-id>
</element-citation>
</ref>
<ref id="b66"><label>66</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doshi</surname>
<given-names>P</given-names>
</name>
<name><surname>Bhargava</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Hypersexuality following subthalamic nucleus stimulation for Parkinson's disease</article-title>
<source>Neurol India</source>
<year>2008</year>
<volume>56</volume>
<fpage>474</fpage>
<lpage>476</lpage>
<pub-id pub-id-type="pmid">19127045</pub-id>
</element-citation>
</ref>
<ref id="b67"><label>67</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname>
<given-names>MS</given-names>
</name>
<name><surname>Gallo</surname>
<given-names>BV</given-names>
</name>
<name><surname>Mandybur</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial</article-title>
<source>Lancet Neurol</source>
<year>2012</year>
<volume>11</volume>
<fpage>140</fpage>
<lpage>149</lpage>
<pub-id pub-id-type="pmid">22239915</pub-id>
</element-citation>
</ref>
<ref id="b68"><label>68</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derost</surname>
<given-names>PP</given-names>
</name>
<name><surname>Ouchchane</surname>
<given-names>L</given-names>
</name>
<name><surname>Morand</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population?</article-title>
<source>Neurology</source>
<year>2007</year>
<volume>68</volume>
<fpage>1345</fpage>
<lpage>1355</lpage>
<pub-id pub-id-type="pmid">17452578</pub-id>
</element-citation>
</ref>
<ref id="b69"><label>69</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname>
<given-names>A</given-names>
</name>
<name><surname>Gill</surname>
<given-names>S</given-names>
</name>
<name><surname>Varma</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial</article-title>
<source>Lancet Neurol</source>
<year>2010</year>
<volume>9</volume>
<fpage>581</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="pmid">20434403</pub-id>
</element-citation>
</ref>
<ref id="b70"><label>70</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dams</surname>
<given-names>J</given-names>
</name>
<name><surname>Bornschein</surname>
<given-names>B</given-names>
</name>
<name><surname>Reese</surname>
<given-names>JP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review</article-title>
<source>Pharmacoeconomics</source>
<year>2011</year>
<volume>29</volume>
<fpage>1025</fpage>
<lpage>1049</lpage>
<pub-id pub-id-type="pmid">22077577</pub-id>
</element-citation>
</ref>
<ref id="b71"><label>71</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McIntosh</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Perspective on the economic evaluation of deep brain stimulation</article-title>
<source>Front Integr Neurosci</source>
<year>2011</year>
<volume>5</volume>
<fpage>19</fpage>
<pub-id pub-id-type="pmid">21779238</pub-id>
</element-citation>
</ref>
<ref id="b72"><label>72</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valldeoriola</surname>
<given-names>F</given-names>
</name>
<name><surname>Morsi</surname>
<given-names>O</given-names>
</name>
<name><surname>Tolosa</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease</article-title>
<source>Mov Disord</source>
<year>2007</year>
<volume>22</volume>
<fpage>2183</fpage>
<lpage>2191</lpage>
<pub-id pub-id-type="pmid">17724747</pub-id>
</element-citation>
</ref>
<ref id="b73"><label>73</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spottke</surname>
<given-names>EA</given-names>
</name>
<name><surname>Volkmann</surname>
<given-names>J</given-names>
</name>
<name><surname>Lorenz</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus</article-title>
<source>J Neurol</source>
<year>2002</year>
<volume>249</volume>
<fpage>759</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="pmid">12111311</pub-id>
</element-citation>
</ref>
<ref id="b74"><label>74</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraix</surname>
<given-names>V</given-names>
</name>
<name><surname>Houeto</surname>
<given-names>JL</given-names>
</name>
<name><surname>Lagrange</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease</article-title>
<source>Neurol Neurosurg Psychiatry</source>
<year>2006</year>
<volume>77</volume>
<fpage>443</fpage>
<lpage>449</lpage>
</element-citation>
</ref>
<ref id="b75"><label>75</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname>
<given-names>E</given-names>
</name>
<name><surname>D'Haese</surname>
<given-names>PF</given-names>
</name>
<name><surname>Dawant</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deep brain stimulation in early stage Parkinson's disease: operative experience from a prospective randomised clinical trial</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>2012</year>
<volume>83</volume>
<fpage>164</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">21890575</pub-id>
</element-citation>
</ref>
<ref id="b76"><label>76</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schupbach</surname>
<given-names>WM</given-names>
</name>
<name><surname>Maltete</surname>
<given-names>D</given-names>
</name>
<name><surname>Houeto</surname>
<given-names>JL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial</article-title>
<source>Neurology</source>
<year>2007</year>
<volume>68</volume>
<fpage>267</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="pmid">17151341</pub-id>
</element-citation>
</ref>
<ref id="b77"><label>77</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agid</surname>
<given-names>Y</given-names>
</name>
<name><surname>Schupbach</surname>
<given-names>M</given-names>
</name>
<name><surname>Gargiulo</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so?</article-title>
<source>J Neural Transm Suppl</source>
<year>2006</year>
<issue>70</issue>
<fpage>409</fpage>
<lpage>414</lpage>
<pub-id pub-id-type="pmid">17017560</pub-id>
</element-citation>
</ref>
<ref id="b78"><label>78</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname>
<given-names>MS</given-names>
</name>
<name><surname>Wu</surname>
<given-names>SS</given-names>
</name>
<name><surname>Foote</surname>
<given-names>KD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease?</article-title>
<source>Neurosurgery</source>
<year>2011</year>
<volume>69</volume>
<fpage>357</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="pmid">21415789</pub-id>
</element-citation>
</ref>
<ref id="b79"><label>79</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name><surname>Hamasaki</surname>
<given-names>T</given-names>
</name>
<name><surname>Kuratsu</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease—retrospective evaluation of postoperative independence in pursuing daily activities</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2009</year>
<volume>15</volume>
<fpage>746</fpage>
<lpage>751</lpage>
<pub-id pub-id-type="pmid">19481492</pub-id>
</element-citation>
</ref>
<ref id="b80"><label>80</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deuschl</surname>
<given-names>G</given-names>
</name>
<name><surname>Schüpbach</surname>
<given-names>M</given-names>
</name>
<name><surname>Knudsen</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2013</year>
<volume>19</volume>
<fpage>56</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">22841616</pub-id>
</element-citation>
</ref>
<ref id="b81"><label>81</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuepbach</surname>
<given-names>WMM</given-names>
</name>
<name><surname>Rau</surname>
<given-names>J</given-names>
</name>
<name><surname>Knudsen</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurostimulation for Parkinson's disease with early motor complications</article-title>
<source>N Engl J Med</source>
<year>2013</year>
<volume>368</volume>
<fpage>610</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="pmid">23406026</pub-id>
</element-citation>
</ref>
<ref id="b82"><label>82</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espay</surname>
<given-names>AJ</given-names>
</name>
<name><surname>Vaughan</surname>
<given-names>JE</given-names>
</name>
<name><surname>Marras</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson's disease: a decision analysis</article-title>
<source>Mov Disord</source>
<year>2010</year>
<volume>25</volume>
<fpage>1456</fpage>
<lpage>1463</lpage>
<pub-id pub-id-type="pmid">20629150</pub-id>
</element-citation>
</ref>
<ref id="b83"><label>83</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merola</surname>
<given-names>A</given-names>
</name>
<name><surname>Zibetti</surname>
<given-names>M</given-names>
</name>
<name><surname>Artusi</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>2012</year>
<volume>83</volume>
<fpage>251</fpage>
<lpage>257</lpage>
<pub-id pub-id-type="pmid">22180646</pub-id>
</element-citation>
</ref>
<ref id="b84"><label>84</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olanow</surname>
<given-names>CW</given-names>
</name>
<name><surname>Kieburtz</surname>
<given-names>K</given-names>
</name>
<name><surname>Schapira</surname>
<given-names>AH</given-names>
</name>
</person-group>
<article-title>Why have we failed to achieve neuroprotection in Parkinson's disease?</article-title>
<source>Ann Neurol</source>
<year>2008</year>
<volume>64</volume>
<issue>suppl 2</issue>
<fpage>S101</fpage>
<lpage>S110</lpage>
<pub-id pub-id-type="pmid">19127580</pub-id>
</element-citation>
</ref>
<ref id="b85"><label>85</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname>
<given-names>JA</given-names>
</name>
<name><surname>Rodriguez-Oroz</surname>
<given-names>MC</given-names>
</name>
<name><surname>Goetz</surname>
<given-names>CG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Missing pieces in the Parkinson's disease puzzle</article-title>
<source>Nat Med</source>
<year>2010</year>
<volume>16</volume>
<fpage>653</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="pmid">20495568</pub-id>
</element-citation>
</ref>
<ref id="b86"><label>86</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname>
<given-names>AH</given-names>
</name>
<name><surname>Tolosa</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Molecular and clinical prodrome of Parkinson disease: implications for treatment</article-title>
<source>Nat Rev Neurol</source>
<year>2010</year>
<volume>6</volume>
<fpage>309</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">20479780</pub-id>
</element-citation>
</ref>
<ref id="b87"><label>87</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spieles-Engemann</surname>
<given-names>AL</given-names>
</name>
<name><surname>Behbehani</surname>
<given-names>MM</given-names>
</name>
<name><surname>Collier</surname>
<given-names>TJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss</article-title>
<source>Neurobiol Dis</source>
<year>2010</year>
<volume>39</volume>
<fpage>105</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="pmid">20307668</pub-id>
</element-citation>
</ref>
<ref id="b88"><label>88</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maesawa</surname>
<given-names>S</given-names>
</name>
<name><surname>Kaneoke</surname>
<given-names>Y</given-names>
</name>
<name><surname>Kajita</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons</article-title>
<source>J Neurosurg</source>
<year>2004</year>
<volume>100</volume>
<fpage>679</fpage>
<lpage>687</lpage>
<pub-id pub-id-type="pmid">15070123</pub-id>
</element-citation>
</ref>
<ref id="b89"><label>89</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harnack</surname>
<given-names>D</given-names>
</name>
<name><surname>Meissner</surname>
<given-names>W</given-names>
</name>
<name><surname>Jira</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism</article-title>
<source>Exp Neurol</source>
<year>2008</year>
<volume>210</volume>
<fpage>257</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="pmid">18036524</pub-id>
</element-citation>
</ref>
<ref id="b90"><label>90</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname>
<given-names>GA</given-names>
</name>
<name><surname>Nikkhah</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions</article-title>
<source>Exp Neurol</source>
<year>2001</year>
<volume>171</volume>
<fpage>405</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">11573992</pub-id>
</element-citation>
</ref>
<ref id="b91"><label>91</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname>
<given-names>XD</given-names>
</name>
<name><surname>Cao</surname>
<given-names>YQ</given-names>
</name>
<name><surname>Liu</surname>
<given-names>HH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Long term high frequency stimulation of STN increases dopamine in the corpus striatum of hemiparkinsonian rhesus monkey</article-title>
<source>Brain Res</source>
<year>2009</year>
<volume>1286</volume>
<fpage>230</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="pmid">19563788</pub-id>
</element-citation>
</ref>
<ref id="b92"><label>92</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname>
<given-names>BA</given-names>
</name>
<name><surname>Ashkan</surname>
<given-names>K</given-names>
</name>
<name><surname>Heise</surname>
<given-names>CE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys</article-title>
<source>Brain</source>
<year>2007</year>
<volume>130</volume>
<fpage>2129</fpage>
<lpage>2145</lpage>
<pub-id pub-id-type="pmid">17584773</pub-id>
</element-citation>
</ref>
<ref id="b93"><label>93</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname>
<given-names>VE</given-names>
</name>
<name><surname>Keay</surname>
<given-names>KA</given-names>
</name>
<name><surname>Ashkan</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus</article-title>
<source>Parkinsonism Relat Disord</source>
<year>2010</year>
<volume>16</volume>
<fpage>338</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">20227323</pub-id>
</element-citation>
</ref>
<ref id="b94"><label>94</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charles</surname>
<given-names>PD</given-names>
</name>
<name><surname>Gill</surname>
<given-names>CE</given-names>
</name>
<name><surname>Davis</surname>
<given-names>TL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Is deep brain stimulation neuroprotective if applied early in the course of PD?</article-title>
<source>Nat Clin Pract Neurol</source>
<year>2008</year>
<volume>4</volume>
<fpage>424</fpage>
<lpage>426</lpage>
<pub-id pub-id-type="pmid">18594505</pub-id>
</element-citation>
</ref>
<ref id="b95"><label>95</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wichmann</surname>
<given-names>T</given-names>
</name>
<name><surname>DeLong</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Deep brain stimulation for neurologic and neuropsychiatric disorders</article-title>
<source>Neuron</source>
<year>2006</year>
<volume>52</volume>
<fpage>197</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">17015236</pub-id>
</element-citation>
</ref>
<ref id="b96"><label>96</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wichmann</surname>
<given-names>T</given-names>
</name>
<name><surname>Bergman</surname>
<given-names>H</given-names>
</name>
<name><surname>DeLong</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism</article-title>
<source>J Neurophysiol</source>
<year>1994</year>
<volume>72</volume>
<fpage>521</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="pmid">7983516</pub-id>
</element-citation>
</ref>
<ref id="b97"><label>97</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname>
<given-names>TP</given-names>
</name>
<name><surname>Carbon</surname>
<given-names>M</given-names>
</name>
<name><surname>Tang</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metabolic correlates of subthalamic nucleus activity in Parkinson's disease</article-title>
<source>Brain</source>
<year>2008</year>
<volume>131</volume>
<fpage>1373</fpage>
<lpage>1380</lpage>
<pub-id pub-id-type="pmid">18400841</pub-id>
</element-citation>
</ref>
<ref id="b98"><label>98</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckert</surname>
<given-names>T</given-names>
</name>
<name><surname>Tang</surname>
<given-names>C</given-names>
</name>
<name><surname>Eidelberg</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Assessment of the progression of Parkinson's disease: a metabolic network approach</article-title>
<source>Lancet Neurol</source>
<year>2007</year>
<volume>6</volume>
<fpage>926</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="pmid">17884682</pub-id>
</element-citation>
</ref>
<ref id="b99"><label>99</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asanuma</surname>
<given-names>K</given-names>
</name>
<name><surname>Tang</surname>
<given-names>C</given-names>
</name>
<name><surname>Ma</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Network modulation in the treatment of Parkinson's disease</article-title>
<source>Brain</source>
<year>2006</year>
<volume>129</volume>
<fpage>2667</fpage>
<lpage>2678</lpage>
<pub-id pub-id-type="pmid">16844713</pub-id>
</element-citation>
</ref>
<ref id="b100"><label>100</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amtage</surname>
<given-names>F</given-names>
</name>
<name><surname>Henschel</surname>
<given-names>K</given-names>
</name>
<name><surname>Schelter</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High functional connectivity of tremor related subthalamic neurons in Parkinson's disease</article-title>
<source>Clin Neurophysiol</source>
<year>2009</year>
<volume>120</volume>
<fpage>1755</fpage>
<lpage>1761</lpage>
<pub-id pub-id-type="pmid">19632151</pub-id>
</element-citation>
</ref>
<ref id="b101"><label>101</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname>
<given-names>AH</given-names>
</name>
<name><surname>Obeso</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Timing of treatment initiation in Parkinson's disease: a need for reappraisal?</article-title>
<source>Ann Neurol</source>
<year>2006</year>
<volume>59</volume>
<fpage>559</fpage>
<lpage>562</lpage>
<pub-id pub-id-type="pmid">16489611</pub-id>
</element-citation>
</ref>
<ref id="b102"><label>102</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnke</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>STN stimulation and neuroprotection in Parkinson's disease—when beautiful theories meet ugly facts</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>2005</year>
<volume>76</volume>
<fpage>1186</fpage>
<lpage>1187</lpage>
<pub-id pub-id-type="pmid">16107346</pub-id>
</element-citation>
</ref>
<ref id="b103"><label>103</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilker</surname>
<given-names>R</given-names>
</name>
<name><surname>Portman</surname>
<given-names>AT</given-names>
</name>
<name><surname>Voges</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation</article-title>
<source>J Neurol Neurosurg Psychiatry</source>
<year>2005</year>
<volume>76</volume>
<fpage>1217</fpage>
<lpage>1221</lpage>
<pub-id pub-id-type="pmid">16107354</pub-id>
</element-citation>
</ref>
<ref id="b104"><label>104</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimura</surname>
<given-names>T</given-names>
</name>
<name><surname>Yamaguchi</surname>
<given-names>K</given-names>
</name>
<name><surname>Ando</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study</article-title>
<source>J Neurosurg</source>
<year>2005</year>
<volume>103</volume>
<fpage>968</fpage>
<lpage>973</lpage>
<pub-id pub-id-type="pmid">16381182</pub-id>
</element-citation>
</ref>
<ref id="b105"><label>105</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temperli</surname>
<given-names>P</given-names>
</name>
<name><surname>Ghika</surname>
<given-names>J</given-names>
</name>
<name><surname>Villemure</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>How do parkinsonian signs return after discontinuation of subthalamic DBS?</article-title>
<source>Neurology</source>
<year>2003</year>
<volume>60</volume>
<fpage>78</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="pmid">12525722</pub-id>
</element-citation>
</ref>
<ref id="b106"><label>106</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hariz</surname>
<given-names>MI</given-names>
</name>
<name><surname>Johansson</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency</article-title>
<source>Mov Disord</source>
<year>2001</year>
<volume>16</volume>
<fpage>166</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">11215582</pub-id>
</element-citation>
</ref>
<ref id="b107"><label>107</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahn</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>How do you treat motor complications in Parkinson's disease: medicine, surgery, or both?</article-title>
<source>Ann Neurol</source>
<year>2008</year>
<volume>64</volume>
<issue>suppl 2</issue>
<fpage>S56</fpage>
<lpage>S64</lpage>
<pub-id pub-id-type="pmid">19127577</pub-id>
</element-citation>
</ref>
<ref id="b108"><label>108</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilker</surname>
<given-names>R</given-names>
</name>
<name><surname>Voges</surname>
<given-names>J</given-names>
</name>
<name><surname>Weisenbach</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease</article-title>
<source>J Cereb Blood Flow Metab</source>
<year>2004</year>
<volume>24</volume>
<fpage>7</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">14688612</pub-id>
</element-citation>
</ref>
<ref id="b109"><label>109</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalbe</surname>
<given-names>E</given-names>
</name>
<name><surname>Voges</surname>
<given-names>J</given-names>
</name>
<name><surname>Weber</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease</article-title>
<source>Neurology</source>
<year>2009</year>
<volume>72</volume>
<fpage>42</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="pmid">19122029</pub-id>
</element-citation>
</ref>
<ref id="b110"><label>110</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hely</surname>
<given-names>MA</given-names>
</name>
<name><surname>Reid</surname>
<given-names>WG</given-names>
</name>
<name><surname>Adena</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years</article-title>
<source>Mov Disord</source>
<year>2008</year>
<volume>23</volume>
<fpage>837</fpage>
<lpage>844</lpage>
<pub-id pub-id-type="pmid">18307261</pub-id>
</element-citation>
</ref>
<ref id="b111"><label>111</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname>
<given-names>JA</given-names>
</name>
<name><surname>Olanow</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Deep brain stimulation for Parkinson's disease: thinking about the long-term in the short-term</article-title>
<source>Mov Disord</source>
<year>2011</year>
<volume>26</volume>
<fpage>2303</fpage>
<lpage>2304</lpage>
<pub-id pub-id-type="pmid">22109849</pub-id>
</element-citation>
</ref>
<ref id="b112"><label>112</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamani</surname>
<given-names>C</given-names>
</name>
<name><surname>Richter</surname>
<given-names>E</given-names>
</name>
<name><surname>Schwalb</surname>
<given-names>JM</given-names>
</name>
<name><surname>Lozano</surname>
<given-names>AM</given-names>
</name>
</person-group>
<article-title>Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature</article-title>
<source>Neurosurgery</source>
<year>2005</year>
<volume>56</volume>
<fpage>1313</fpage>
<lpage>1321</lpage>
<pub-id pub-id-type="pmid">15918948</pub-id>
</element-citation>
</ref>
<ref id="b113"><label>113</label>
<element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shichi</surname>
<given-names>T</given-names>
</name>
<name><surname>Okiyama</surname>
<given-names>R</given-names>
</name>
<name><surname>Yokochi</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Unilateral subthalamic stimulation for early-stage Parkinson's disease [in Japanese]</article-title>
<source>No To Shinkei</source>
<year>2005</year>
<volume>57</volume>
<fpage>495</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="pmid">16026045</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Pmc/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000920 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000920 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:4065356
   |texte=   Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:23483564" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

Timing of Deep Brain Stimulation in Parkinson Disease: A Need for Reappraisal?

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki